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ABSTRACT 
 
During human spaceflight missions, controlled variation of atmospheric pressure 
and oxygen concentration from a sea- level based normal to hyperoxic levels may occur 
as part of operational procedure. This activity is of interest because it provides the 
relevant radiation exposure and dynamic oxygen concentration parameters that may lead 
to varying radiation sensitivity in the skin and other organs.  
Tumor hypoxia has been indicated as a primary factor in the decrease in efficacy 
of radiation therapy. These oxygen concentration effects have been largely demonstrated 
with low-LET radiations and to a lesser degree with high-LET primary radiations such 
as protons and heavy ions common in space exposure. 
In order to analyze the variation of oxygen concentration in human skin from 
spaceflight activities, a mathematical model of oxygen transport through the human 
cardiorespiratory system with pulmonary and cutaneous intake was implemented. 
Oxygen concentration was simulated at the various skin layers, from dermis to 
epidermis. Skin surface radiation doses and spectra from relatively high flux Solar 
Particle Events (SPEs) were calculated by the PHITS radiation transport code over a 
range of spacecraft and spacesuit thicknesses in terms of aluminum equivalence. A series 
of anatomical skin and shielding thicknesses were chosen to encompass the scope of 
radiation exposure levels as indicated by existing NASA skin phantom studies. 
To model the influence of oxygen with radiation exposure, microdosimetric 
oxygen fixation simulations were implemented using the Monte-Carlo-Damage-
Simulation (MCDS) code. From these outputs, occurrence of DNA double strand breaks 
  iii 
(DSBs) and relative biological effect (RBE) from radiation exposure with oxygen 
concentration dependence was established and correlated to spaceflight activities.  
It was determined that minimal but observable oxygen concentration transients 
occur in skin during environmental oxygen changes in spaceflight. The most significant 
transients occurred in the thickest epidermal layers with relatively high amounts of 
diffusion. Accordingly, these thickest epidermal layers also showed the greatest 




  iv 
DEDICATION 
 
This dissertation is dedicated to my wife Ruth and my three children Kaylee, 













  v 
ACKNOWLEDGEMENTS 
I would like to thank the National Science Foundation’s Bridge to Doctorate 
Program and the Texas A&M LSAMP program for their financial support early in my 
graduate career.   
I would also like to thank the National Space Biomedical Research Institute’s 
Space Life Sciences program for introducing me to space radiation subject matter.  
Finally, I would like to thank my advisory committee and Dr. Stephen 
Guetersloh for their patience, guidance and knowledge.  
vi 
TABLE OF CONTENTS 
   Page 
ABSTRACT ..............................................................................................................  ii 
DEDICATION ..........................................................................................................  iv 
ACKNOWLEDGEMENTS ......................................................................................  v 
TABLE OF CONTENTS ..........................................................................................  vi 
LIST OF FIGURES ...................................................................................................  viii 
LIST OF TABLES ....................................................................................................  xii 
1. INTRODUCTION ............................................................................................... 1 
1.1 Overview .......................................................................................................  1 
1.2 Description of the Space Radiation Environment .........................................  2 
1.3 Variation of the Atmospheric Environment for Human Spaceflight.............  5 
1.4 Evidence for the Biological Significance of Oxygen Variation ....................  8 
2. SIMULATION METHODS ................................................................................ 13 
2.1 Outline  ..........................................................................................................  13 
      2.2 Estimation of Incident Solar Particle Spectra ...............................................  15 
2.3 Radiation Transport and Incident Radiation to Skin .....................................  18 
2.4 Atmospheric Oxygen Transport to the Human Skin .....................................  24 
2.5 Oxygen Dependence Simulation ...................................................................  35 
3. RESULTS AND DISCUSSION.......................................................................... 38 
3.1 Solar Particle Transport and Energy Deposition in Matter ...........................  38 
3.2 Particle Flux Incident on Skin .......................................................................  46 
3.3 Oxygen Tension in Epidermal Layers ...........................................................  55 
4. SUMMARY AND CONCLUSIONS..................................................................
4.1 Hypoxic Reduction Factor and Resultant Biological Effect .........................  71 
4.2 Discussion and Relevance for Space Mission Architecture  ..........................  80 
4.3 Future Work and Additional Applications ....................................................  81 
REFERENCES ..........................................................................................................  83 
71 
vii 
APPENDIX A. SOLAR PARTICLE EVENT SPECTRA........................................  91 
APPENDIX B. UTILIZED CODES AND SCRIPTS ...............................................  95 
B.1 MATLAB Total Flux Scaling Code .............................................................  95 
B.2 MATLAB Script for Import of PHITS Output.............................................. 95 
B.3 Mathematica Script for Oxygen Concentration Gradient .............................  98 
B.4 Sample PHITS Input Code ...........................................................................  100 
B.5 Sample PHITS Output (Incident Skin Spectra)  ...........................................  105 
APPENDIX C. PARAMETERS AND INITIAL CONDITIONS FOR PNEUMA..  112 
  viii 
LIST OF FIGURES 
 
FIGURE                                                                                                                        Page 
1. Spectral summary of space radiations .................................................................  4 
 
2. International Space Station ETHOS life support system display ........................  8 
 
3. Dose rate from the August 72´SPE with 0.3 gm/cm2 shielding ..........................  9 
 
4. Radiotherapy patient exposed to perpendicular proton radiation ........................  10 
 
5. Outline of simulation procedure ..........................................................................  13 
 
6. Proton spectra for five events in October / November 2003 ...............................  17 
7. Ion spectra for an SPE in January of 2005 ..........................................................  19 
8. Outline of the PHITS radiation transport code ....................................................  20 
9. Dose Equivalent calculated by. PHITS, OLTARIS (HZETRN) and MCNPX at 
various depths of water after 20 gm/cm2 of aluminum for four SPE events .......  21 
 
10. Comparison between FLUKA, PHITS and MCNPX calculated and measured 
differential neutron yield as a function of incident angle from a 4.6 cm aluminum 
target bombarded by 113 MeV incident protons .................................................  22 
 
11. Epidermal components to be simulated. ..............................................................  23 
12. Oxyhemoglobin saturation curve ........................................................................  26 
13. Cardiorespiratory model, PNEUMA ...................................................................  28 
14. PNEUMA arterial and alveolar partial pressures associated with gas exchange in 
the lungs...............................................................................................................  30 
 
15. PNEUMA outputs from 100% oxygen breathing at 1 atmosphere at t=0 ...........  33 
16. Visual depiction of oxygen-hemoglobin binding on red blood cells in plasma ..  34 
17. MCDS simulations of OER vs LET by particles type.........................................  37 
  ix 
18. Flux normalized energy deposited as a function of depth with 5 gm/cm2 of 
aluminum equivalent shielding from 1956, 1960, 1972, and 1989 SPEs............  40 
 
19. Energy deposited as a function of depth with 5 gm/cm2 of aluminum equivalent 
shielding from 1956, 1960, 1972, and 1989 SPEs ..............................................  42 
 
20. Comparison of the predicted skin dose rates for the August 1972 and October 
1989 SPEs as a function of time since event onset and behind 2 g/cm2 aluminum 
shielding ..............................................................................................................  42 
 
21. Comparison of energy differential particle fluence for the August 1972 and 
October 1989 SPEs ..............................................................................................  43 
 
22. Energy deposited as a function of depth with 5 gm/cm2 of aluminum equivalent 
shielding from 1956, 1960, 1972, and 1989 SPEs ..............................................  44 
 
23. Energy deposited as a function of depth with 12.5 gm/cm2 of aluminum 
equivalent shielding from 1956, 1960, 1972, and 1989 SPEs .............................  45 
 
24. Energy deposited as a function of depth with 0.2 gm/cm2 of aluminum equivalent 
shielding from 1956, 1960, 1972, and 1989 SPEs ..............................................  45 
 
25. Proton flux as a function of energy behind 0.1 cm (0.27 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs ....................................................  47 
 
26. Proton flux as a function of energy behind 1 cm (2.7 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs ....................................................  47 
 
27. Proton flux as a function of energy behind 5 cm (13.5 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs ....................................................  48 
 
28. Proton flux as a function of energy behind 13.5 cm (36.5 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs ....................................................  48 
 
29. Neutron flux as a function of energy behind 0.1 cm (0.27 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs ....................................................  49 
 
30. Neutron flux as a function of energy behind 1 cm (2.7 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs ....................................................  50 
 
31. Neutron flux as a function of energy behind 5 cm (13.5 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs.  ...................................................  51 
 
  x 
32. Neutron flux as a function of energy behind 13.5 cm (36.5 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs.  ...................................................  51 
 
33. Electron flux as a function of energy behind 0.1 cm (0.27 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs ....................................................  52 
 
34. Electron flux as a function of energy behind 1 cm (2.7 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs.  ...................................................  53 
 
35. Electron flux as a function of energy behind 5 cm (13.5 gm/cm2 ) of aluminum 
equivalent shielding for 1972, and 1989 SPEs ....................................................  53 
 
36. Alpha paticle flux as a function of energy behind 0.1 cm (0.27 gm/cm2) of 
aluminum equivalent shielding for 1972, and 1989 SPEs...................................  54 
 
37. Alpha particle flux as a function of energy behind 1 cm (2.7 gm/cm2 ) of 
aluminum equivalent shielding for 1972, and 1989 SPEs...................................  55 
 
38. Normoxic breathing at 1 atmosphere at t=0 ........................................................  62 
 
39. Hyperoxic breathing at 1 atmosphere at t=0........................................................  62 
 
40. Oxygen concentration gradient from a thin skin surface with 100% oxygen 
breathing at 1 atmosphere from t=0.....................................................................  64 
 
41. Detailed view of the oxygen concentration gradient from a thin skin surface with 
100% oxygen breathing at 1 atmosphere from t=0 .............................................  65 
 
42. Oxygen concentration gradient from a medium thickness skin surface with 100% 
oxygen breathing at 1 atmosphere from t=0........................................................  65 
 
43. Detailed view of the oxygen concentration gradient from a medium thickness 
skin surface with 100% oxygen breathing at 1 atmosphere from t=0 .................  66 
 
44. Oxygen tension gradient from a thick skin surface with 100% oxygen breathing 
at 1 atmosphere from t=0.....................................................................................  67 
 
45. Detailed view of the oxygen tension gradient from a thick skin surface with 
100% oxygen breathing at 1 atmosphere from t=0 .............................................  67 
 
46. Steady-state oxygen concentration gradient from a thin, thick and thick skin 
surfaces at 100% oxygen breathing at 1 atmosphere...........................................  68 
 
xi 
47. Oxygen concentration gradient from a thick skin surfaces with initial 21%
oxygen breathing at 1 atmosphere with a transition to 100% oxygen breathing
at t > 540s ............................................................................................................           69 
48. Oxygen concentration gradient from a thin skin surfaces at 21% oxygen
breathing at 1 atmosphere with a termination of arterial blood oxygen at t > 5s 70 
49. Flux-averaged HRFs for all SPEs and shielding thicknesses versus oxygen partial 
pressure present in tissue .....................................................................................  72 
50. Exploded view of flux-averaged HRFs for all SPEs and shielding thicknesses
versus oxygen partial pressure.............................................................................  73 
51. Exploded view of flux-averaged HRFs for all SPEs and shielding thicknesses
versus oxygen partial pressure.............................................................................  74 
52. HRF gradient for thin and medium thickness epidermal skin under normoxic
conditions ............................................................................................................  75 
53. HRF gradient for thick epidermal skin under normoxic conditions .................... 76 
54. HRF comparison gradient between normoxic and hyperoxic conditions for thin
and medium thickness epidermal skin.................................................................  77 
55. HRF comparison gradient between normoxic and hyperoxic conditions for thick
epidermal skin .....................................................................................................  77 
56. Transient Relative Biological Effect (RBEskin-transient) for thin and medium
thickness epidermal skin......................................................................................  78 
57. Transient Relative Biological Effect (RBEtransient) for thick epidermal skin ....... 79 
  xii 
LIST OF TABLES 
 
TABLE                                                                                                                          Page 
 
1. Dose thresholds for respective skin deterministic effects  ...................................  12 
2. Summary of SPE data sources.............................................................................  18 
3. Total particle flux percent for the August 1972 SPE transported by PHITS vs. 
aluminum thicknesses of 0.1, 1, 5 and 13.5 cm...................................................  39 
 
4. Total particle flux for selected SPE data sets ......................................................  41 
5. Epidermal simulation thicknesses .......................................................................  56 
6. Constants utilized in the oxygen diffusions simulation.......................................  58 
7. Oxygen consumption parameters as applied to Michaelis-Menten kinetics .......  60 
 
  




Continuous and relatively high exposure from energetic ions to spaceflight 
participants outside the earth's atmosphere is a notable concern during human 
spaceflight. In addition, operational logistics of this radiation exposure vary with 
spacecraft shielding materials, thickness and variable atmospheric mediums. This 
activity is of interest because it provides the relevant radiation exposure and dynamic 
oxygen concentration parameters that may lead to varying radiation sensitivity in the 
skin and other organs. 
Exposures that could potentially lead to acute or deterministic biological effects 
are commonly associated with Solar Particles Events (SPEs). Due to the potential of 
significant deterministic effects from exposure to these particles, planning and 
countermeasures to mitigate this exposure are a necessary component of spaceflight 
planning.  
The dependence on shielding thickness and material type is well documented as a 
significant factor in net exposure from SPEs (Lin et al., 2012; Zeitlin, Guetersloh, 
Heilbronn, & Miller, 2005; Zeitlin, Heilbronn, Miller, & Shavers, 2001). Shielding can 
modify particle energy spectra thus modifying the absorbed dose, energy distributions, 
quality factor or other derived weighting factors of these radiations. Factors that may 
modify these results are of great interest in the effort to optimize spacecraft and habitat 
design. 
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Prevailing human spaceflight procedures utilize variation in atmospheric content 
and pressure for various work functions and individual comfort, including a wide 
variation of oxygen content. During extravehicular activity (EVA), which requires 
pressures considerably below one atmosphere, procedures require the change of the 
oxygen content from the Earth-based normal of 21% to near 100% in order to combat 
decompression sickness (Thomas, 2006). In addition, hyperbaric exposures have been 
indicated for treatment of decompression sickness (DCS) or air embolism caused from 
spaceflight activities (Huntoon, 1996).   
In an attempt to simulate these attributes of the spaceflight environment, an 
anthropomorphic model of the human skin with defined oxygen tension was created 
based on gas transport and diffusion. In order to simulate oxygen-dependent changes in 
RBE in this model, the Monte-Carlo-Damage-Simulation (MCDS) (Carlson, Stewart, 
Semenenko, & Sandison, 2008; Stewart et al., 2011) code, which is validated against cell 
death and chromosome aberration studies was utilized. This served as a radiation target 
for simulations with the PHITS radiation transport software. From these simulations 
transients in Relative Biological Effect (RBE) from SPEs were assessed. 
 
1.2 Description of the Space Radiation Environment 
 
 The radiation field that astronauts are exposed to in space is complex compared 
to that of ground-based radiation workers. It contains photons, electrons, protons, alpha 
particles, and heavier ions up to very high energies with origins outside our solar system. 
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The sun emits high fluxes of mostly protons, with some heavy ions and electrons. These 
radiations may subsequently become trapped in belts by the magnetic field of the Earth 
and/or cause secondary radiations including neutrons created by interactions with 
materials of the spacecraft. Ionizing radiation doses to astronauts in space are on the 
order of 1-3 mSv per day and depending on the time spent in space they may exceed 100 
mSv total. It is common occurrence for astronaut exposures to exceed annual (50 mSv) 
and lifetime dose limits for ground-based radiation workers proposed by the 
International Commission of Radiation Protection (ICRP).  
Galactic Cosmic Radiation (GCR) ion spectra with origins from supernovae and 
other astronomical events are the most continuously prevalent ionizing radiation 
exposures. Within the solar system GCR radiation is modulated by radiation and 
magnetic fields originating from the sun. Within Low Earth Orbit (LEO), the Earth’s 
magnetic field traps low energy protons and electrons resulting in relatively high 
exposures when spacecraft cross the field lines associated with South Atlantic Anomaly 
(SAA) and field lines near the magnetic poles.  Beyond the protection of earth's 
magnetic field and physical shielding, higher exposure rates of GCR are possible in 
addition to the potential of increased exposure from solar radiation. Figure 1 provides an 
outline of the space radiation spectrum. 
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Figure 1. Spectral summary of space radiations (J. W. Wilson, 1978) 
 
The sun continuously emits particle radiation consisting primarily of protons and 
electrons, the solar wind. This radiation is orders of magnitude lower in kinetic energy 
(< 3.5 keV) relative to other galactic radiations and may be shielded by micrometers of 
aluminum or similar shielding.  However, occasionally the shock associated with a 
coronal mass ejection (CME) or the energy released at a solar flare site may accelerate 
these particles to MeV or GeV energies and they may be classified as Solar Energetic 
Particles (SEPs). If these energetic particles reach Earth or a location of interest they 
may be classified as a Solar Particle Event (SPE), this is alternative ly called a Solar 
Proton Event indicating the primary abundance of protons in the particle composition. 
The National Oceanic and Atmospheric Administration’s (NOAA) Space Environment 
Center (SEC) declares an SPE to be in progress when the exposure rate of particles with 
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energies above 10 MeV (i.e., space-suit-penetrating) exceeds 10 particles / cm2-sec-ster 
(directional flux) for more than 15 minutes ("Radiation and the International Space 
Station: Recommendations to Reduce Risk," 2000).  
Unlike GCR, SEPs originate from the Sun and are difficult to predict in intensity 
and occurrence. In addition, for exposure to occur the accelerated particles must interact 
with the solar magnetic field lines in a manner to target Earth or an object of interest. 
The result of this transport across magnetic field lines and primarily Coulombic 
scattering results in a mostly isotropic particle exposure at 1 AU distance for sizes 
comparable to a spacecraft. For larger geometries directionality moving away from the 
solar origin may be established (Dorman & Venkatesan, 1993). 
 
1.3 Variation of the Atmospheric Environment for Human Spaceflight  
 
Variation of atmospheric pressure and content has been a continually evolving 
aspect of spaceflight. Early U.S. manned space vehicles encompassing both Mercury and 
Gemini programs atmospheric pressures were planned at 5 psi with 100% oxygen 
concentration. Nitrogen use was avoided since it brought the risk of decompression 
sickness and additional weight in design. However, during preliminary tests in the 
Apollo 1 spacecraft an accidental fire occurred that resulted in the death of three 
astronauts: Edward White, Gus Grissom and Roger Chaffee. Similarly, On January 28, 
1986 the Soviet Union disclosed that cosmonaut Valentin Bondarenko died after a fire in 
a high-oxygen isolation chamber on March 23, 1961, less than three weeks before the 
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first Vostok manned space flight. These fires were found to be largely promoted from the 
high abundance of oxygen and changes to U.S. spacecraft design were made to reduce 
the risk of fire including decreasing oxygen concentration to 60%. Although the new 
cabin atmosphere was significantly safer than 100% oxygen, it still contained almost 
three times the amount of oxygen present in ordinary sea level air (20.9% oxygen).  This 
relatively high content of oxygen was necessary to ensure that the partial pressure of 
oxygen was maintained at 3 psi. (60% of 5 psi is 3 psi, comparable to 20.9% of 14.7 psi, 
or 3.07 psi in sea- level air)(Vasquez, Pretorius, & Rimkus, 1987) 
These specifications again came under scrutiny under the Apollo-Soyuz Test 
Project (ASTP). The atmospheric pressure and composition inside the Apollo command 
module differed from that used inside the Russian Soyuz spacecraft. The Soyuz uses 80 
% nitrogen 20 % oxygen environment at a pressure of one full atmosphere (14.7 psi). 
Transfer between these two atmospheres would require pre-breathing of pure oxygen to 
purge the blood of dissolved nitrogen. This was avoided by lowering the Soyuz pressure 
to two-thirds atmospheric pressure. The docking module served mainly as an airlock to 
raise or lower the pressure between 1/3 (Apollo) and 2/3 atmospheres when moving 
from one spacecraft to the other. Subsequent U.S. spacecraft have utilized a normal 
atmospheric environment of 1 atm or14.7 psi with 21% oxygen (Thomas, 2006).  
Due to the difficulty in dexterity in pressurized spacesuits both U.S. and Russian 
programs have traditionally utilized pressures lower than 1 atm for EVA. The U.S. Space 
Shuttle, Soyuz and the International Space Station (ISS) operate at 1 atm of pressure. 
Therefore, it is prudent that a pre-breathing procedure to acclimate crewmembers to 
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lower pressured space suits and to avoid decompression sickness. To perform an EVA 
from the U.S. Space Shuttle, the cabin pressure was reduced from 14.7 psi to 10.2 psi for 
approximately 24 hours. In anticipation of further reduced pressure, the crewmembers 
then pre-breathed pure oxygen for 45 minutes prior to initiating the EVA. For EVAs 
initiated from the ISS, crewmembers usually begin the pre-breathe protocol by 
exercising for 10 minutes on a specially designed treadmill for spaceflight while 
breathing pure oxygen via a mask. After nearly an hour of breathing pure oxygen, the 
crewmembers will move to the airlock where pressure is lowered to 10.2 psi as similarly 
done on the shuttle. During depressurization, the crewmembers will breathe pure oxygen 
for an additional 30 minutes. Afterwards, with the airlock now at 10.2 psi the 
crewmembers will put on their space suits. With their spacesuits on, the crewmembers 
will breathe pure oxygen inside the suits for an additional 60 minutes before making 
final preparations to begin their EVA. This results in a total of 2 hours and 20 minutes of 
pure oxygen breathing, including the 10 minutes of exercise at the beginning of the 
procedure. Gradually this time has been extended to 4 hours to reduce risk of 
complications (RD Vann). Publicly available data to view this process is available from 
the Environmental and Thermal Operating (ETHOS) display from the ISS (Figure 2).  
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Figure 2. International Space Station ETHOS life support system display 
(http://spacestationlive.nasa.gov/displays/ethosDisplay1.html). 
 
1.4 Evidence for the Biological Significance of Oxygen Variation 
 
To produce observable deterministic effects to the skin such as erythema, when 
exposure occurs at earth normal atmospheric pressure and oxygen concentration, doses 
above 2 Gy are necessary. These radiation exposures during spaceflight are possible 
from Solar Particle Events (SPEs), which can produce doses that are substantially higher 
within a period of days (Figure 3). SPEs occur often, and it is difficult to predict their 
onset, duration and magnitude. Most SPEs result in insignificant crew doses even for 
light spacecraft or even EVA shielding, and only a small proportion (about 10%) of 
events lead to significant organ doses of >10 mGy-Eq. There is data to indicate five 
Earth-bound SPEs where dose and energy spectra exceeded deterministic effect 
thresholds (1956, 1960, 1972, 1989 x2) (Kim, De Angelis, & Cucinotta, 2011). 
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Figure 3.  Dose rate (cGy/Hr) from the August 72´SPE with 0.3 gm/cm2 shielding. Total 
Skin Dose = 32.15 Gy (S. Hu, Kim, McClellan, & Cucinotta, 2009) 
 
Direct evidence of increased radiosensitivity to the skin in human patients from 
increased diatomic oxygen pressure has been found (Gray, Conger, Ebert, Hornsey, & 
Scott, 1953; van den Brenk, Kerr, Richter, & Papworth, 1965). The radiation sensitivity 
of normal and malignant cells in anoxic condition to low LET radiation varies by factors 
of 2.5–3 as pO2 is increased from <1 mmHg (.02 psi) to 25 mmHg (.48 psi) (Hall, 2006). 
Hypoxia is a common feature of many tumors and a reduction of effectiveness of 
radiation therapy, which is overcome by increased radiation dosage and/or combination 
of hyperbaric treatment, oxygen supplementation and/or pharmaceuticals. In addition, 
erythema has been observed in proton radiotherapy with hypothetical severity apparently 
determined by oxygen tension (Whaley et al., 2013) (Figure 4.). 
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Figure 4. Radiotherapy patient exposed to perpendicular proton radiation. The 
lesser effected center was covered by gas impermeable polyurethane film and acrylate 
film for the entire exposure duration of 6 weeks (Whaley et al., 2013). It is hypothesized 
the lesser-effected center resulted from a hypoxic tension.  
 
Clinically observed deterministic effects from charged particle radiation require 
doses above a threshold.  To produce observable deterministic effects to the skin, a 
minimum of 1-2 Gy is required. Deterministic dose limits from these radiations exist in 
the form of 30 day and 1 year limits that are imposed to US spaceflight participants to 
protect the skin, lens, and blood forming organs (ICRP, 2010) from the occurrence of 
acute health effects such as skin ulceration, moist and dry desquamation, erythema, 
cataracts, inflammatory tissue responses, gastro- intestinal illness and central nervous 
system detriment. These doses are unlikely to be exceeded in LEO, but during Lunar-
type and Martian-type long duration missions it is possible that these may be exceeded if 
protections are not in place, most notably from SPEs.  
In medical x-ray procedures, deterministic skin injury is usually the result of 
exceeding exposure thresholds referenced in ICRP 85 (ICRP, 2010) , NCRP 168 (NCRP, 
2011) or FDA Guidelines (FDA, 1994) and verified by follow up monitoring of the 
exposed skin area. The appearance of initial deterministic injury varies between 
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exposures and individuals resulting in the need for continuous monitoring following a 
qualifying exposure (Koenig, Mettler, & Wagner, 2001). Deterministic injury most often 
presents itself as erythema at absorbed skin surface doses above 2 Gy and substantially 
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Threshold Skin Entrance Doses for Different Skin In juries  
Single-Dose Effect  Threshold (Gy)  Onset 
Early transient erythema  2 Hours 
Main erythema  6 Approximately 10 days 
Late erythema  15 Approximately 6–10 wks  
Temporary epilation  3 Approximately 3 wks  
Permanent epilat ion  7 Approximately 3 wks  
Dry desquamation  14 Approximately 4 wks  
Moist desquamation  18 Approximately 4 wks  
Secondary ulceration  24 Greater than 6 wks 
Ischemic dermal necrosis  18 Greater than 10 wks 
Dermal atrophy (1st phase)  10 Greater than 14 wks 
Dermal atrophy (2nd phase)  10 Greater than 1 yr 
Induration (invasive fibrosis)  10 Unknown  
Telangiectasia  10 Greater than 1 yr 
Late dermal necrosis > 12 
12?  
Greater than 1 yr 
Skin cancer  Stochastic  Greater than 5 yrs 
Table 1. Dose thresholds for respective skin deterministic effects (Hirshfeld et al., 2004) 
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2. SIMULATION METHODS 
2.1 Outline 
 
A range of radiations and atmospheric exposures are possible during spaceflight. 
Much of this variation is attributed to operational logistics, such as compression, 
decompression and change in radiation shielding due to mission activities. In order to 
determine if oxygen variation and differing incident radiation spectra will change the 
resultant skin damage, these attributes were identified and applied in an integrative 
model. A visual representation of the model is presented in Figure 5.  
 
 
Figure 5. Outline of simulation procedure 
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As presented in the figure, radiation and oxygen environments were simulated 
separately and then combined to determine net radiation detriment. In an attempt to 
simulate deterministic skin attributes in the spaceflight environment, an 
anthropomorphic model of the human skin with defined oxygen tension was created 
based on selected gas transport and diffusion models. Oxygen transport is simulated in 
vivo through a cardiorespiratory model called PNEUMA (Hsing-Hua & Khoo, 2002) 
with oxygen tension boundary conditions found in literature (Wang, Winlove, & Michel, 
2003). External oxygen transport was simulated by Fick’s diffusion approximations as 
validated in literature (Stucker et al., 2001). 
In order to simulate oxygen-dependent change in RBE in this model, the Monte-
Carlo-Damage-Simulation (MCDS) code (Carlson et al., 2008; Stewart et al., 2011) was 
utilized. MCDS is verified against cell death and chromosome aberration, an indicator of 
erythema incidence (Peter, 2005). This served as a radiation target for simulations with 
the PHITS radiation transport software (T.  Sato et al., 2013). Variation in radiation 
shielding encompassing the range of spacecraft operations was utilized in the radiation 
transport code. From these simulations, optimal modification to oxygen breathing profile 
and/or operational considerations in order to reduce net deterministic effect from SPEs 
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2.2 Estimation of Incident Solar Particle Spectra  
 
 
 Relatively high-energy particles arrive at Earth orbit first during a SPE and are 
followed by particles of lower energies. As a result the energy distribution of SPE 
particles observed at Earth depends on time after onset of the event. The vast majority o f 
these particles are protons, but modern instrumentation has validated the presence of 
helium, oxygen and iron at orders of magnitude lesser flux. From incident high-energy 
particles, many target fragments have short ranges, on the order of hundreds of microns 
or less in water or tissue. Early particle detectors on satellites and spacecraft had limited 
energy resolution capability. Not until Solar Cycle 23 did new instrumentation make it 
possible to measure the composition and energy spectra of SEP events over a broad 
energy interval (<0.1 to >100 MeV/nuc), including all abundant elements from H to Fe 
(Mewaldt, 2007).  
Initially to overcome limitations in data resolution, Malitson and Weber 
(Malitson & Webber, 1963) suggested an exponential fit to describe the energy spectrum 
of an SPE based on two integrated flux data points. Using these fits the energy spectrum 
was often inaccurate and shown to be erroneous at higher energies. A different fitting 
method using the Weibull function was applied by Xapsos (Xapsos et al., 2000) using 
the Marquardt–Levenberg nonlinear regression routine. However, subsequent studies 
(Atwell, Tylka, Dietrich, Badavi, & Rojdev, 2011) have found high variation in 
individual SPE spectrum. An alternative fitting method called the band function is a 
combination of two integral power law fits. Multiple studies (Tylka & Dietrich, 2008)  
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(Atwell, Tylka, Dietrich, & Badavi, 2008) have applied the band function across several 
SPE spectra with nominal results. Alternatively, Mewaldt (2005, 2007) has found, with 
the increased data resolution provided in Solar Cycle 23 and new Advanced 
Composition Explorer (ACE) satellites a direct single or double power law fit is 
applicable to describe the broad range of SPE spectra.  
Accordingly, using the method prescribed by Mewaldt (2005) for energies above 
10 MeV, SPE particle spectra may be approximated by a single power law:  
 
     
        
     Equation 1 
 
After the onset of the event, the exponent x decreases with time and the 
contribution by high-energy particles to absorbed dose decreases with time during the 
event. The constant Ao describes the absolute number of particles and is highly 
influenced by field irregularities or shock waveforms in the interplanetary medium.  
The more-complex double power law may be used to describe broader energy 
range of SPE spectra. This is primarily useful in examining data when lower energy 
ranges are available. The spectral indices for the high and low energy particles are 
notably different within each event with strong time dependency. In its simplest form, a 
double power law spectrum takes the form: 
 
     
        
                   Equation 2 
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                  Equation 3 
Additional respective constants Bo and X2 are applied to the energy range 
separated by energy cutoff Ec. Exposure to fluxes above 10 MeV can be transported 
through limited shielding, such as a spacesuit and induce adverse skin reactions or 
damage the lens and cornea of the eye. Situations where these lower energies are 
attenuated may be satisfactorily simulated using a single power law. A sample of power 
law indices is provided in Figure 6. 
 
 
Figure 6. Proton spectra for five events in October / November 2003. Both power 
law indices are listed (Mewaldt, 2005).  
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Given the lack of broad justification for a single broad fitting method, differential 
source spectra from published data sets were utilized directly. The following SPE events, 
indicative of potential deterministic effects, were simulated based on the data sets shown 
in Table 2. Graphical representations of these data sets may be found in Appendix A. 
 
SPE Event Date Data Sources Integral Fit  
February 1956 NASA Langley (Wilson) 
(J. W. Wilson, 1976) 
Piecewise Exponential  
ϕ=2.52E9 /cm2  
  Webber (Webber, 1963) Piecewise Power and 
Exponential  
ϕ=1E10 /cm2 
November 1960 NASA Langley (Wilson) 
(J. W. Wilson, 1976) 
Piecewise Exponential 
ϕ=1.8E10 /cm2 
August 1972 NASA Langley (Wilson) 
(J. W. Wilson, 1976) 
Exponential  
ϕ =1.76E10 /cm2 
  King (King, 1974) Exponential in Rigidity 
ϕ =2.33E10 /cm2 
October 1989 NASA Langley (Sauer) 
(Sauer, 1990) 
Double Power Law 
 ϕ =5.21E10 /cm2 
September 1989 NASA Langley (Sauer) 
(Sauer, 1990) 
Double Power Law 
 ϕ =1.41E10 /cm2 
Table 2. Summary of SPE data sources 
 
2.3 Radiation Transport and Incident Radiation to Skin 
 
Incident radiation upon human skin can vary substantially in spaceflight as on 
Earth, depending on source and shielding. Radiation exposure to skin in NASA radiation 
skin studies (Kim, George, & Cucinotta, 2006) (S. Hu et al., 2009) during long duration 
missions is expected to be the most relevant for deterministic effect due to the lack of 
physical and magnetic shielding from Earth. Typical SPE incident spectra was simulated 
using proton nuclei for the significance to deterministic effect as indicated by previous 
  19 
studies(Heinbockel, Slaba, Blattnig, & Tripathi, 2010) (S. Hu et al., 2009; Kim et al., 
2011). Additionally, relative particle fluence from other ions is several orders of lesser 
magnitude (Mewaldt, 2005) (Figure 7). 
 
 
Figure 7. Ion spectra for an SPE in January of 2005. Both power law indices are 
listed (Mewaldt, 2005).  
 
The Particle and Heavy Ion Transport code System (PHITS) is a Monte Carlo-
based radiation transport code, developed by the Japan Atomic Energy Institute (JAERI). 
PHITS radiation transport software has been chosen for use in this model due to 
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previous validation in space radiation studies (T. Sato & Niita, 2006; Sihver, Sato, 
Puchalska, & Reitz, 2010), familiar Monte Carlo N-Particle (MCNP)-like interface and 
highly customizable end data products. A variety of existing libraries and modules create 
a single transport code with applicability to a wide range of energies, forms of radiation, 
and target materials. Figure 8 presents the constituent modules that constitute the full 
PHITS radiation transport software as well as its structure and applicability. 
 
 
Figure 8. Outline of the PHITS radiation transport code. Image obtained from the 
PHITS website (http://phits.jaea.go.jp/image/OvMapOfModels.png) 
 
Numerous comparisons of PHITS with other ion transport codes have been 
published for relevant space environment and proton interaction problems (Aghara, 
Sriprisan, Singleterry, & Sato, 2015; Lin et al., 2012; Oh & Lee, 2011; Sihver et al., 
2008). PHITS results correlate well for both dose equivalent and neutron generation 
results (Figure 9 and Figure 10) obtained with MCNP and FLUtuierende KAskade 
(FLUKA) codes.  Neutrons are a particularly notable contributor to dose from SPEs but 
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lack complete attribution for energies less than 100 MeV in the NASA developed High Z 
and Energy TRaNsport (HZETRN) code (Aghara et al., 2015).  
 
 
Figure 9.  Dose Equivalent calculated by. PHITS, OLTARIS (HZETRN) and 
MCNPX at various depths of water after 20 gm/cm2 of aluminum for four (1956, 1972, 
1989 and 1859 Carrington) SPE events (Aghara et al., 2015).  
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Figure 10. Comparison between FLUKA, PHITS and MCNPX calculated and measured  
(LANL) differential neutron yield as a function of incident angle from a 4.6 cm 
aluminum target bombarded by 113 MeV incident protons (Oh & Lee, 2011). 
 
The Extravehicular Mobility Suit (EMU) manufactured for NASA by ILC Dover, 
is the current design of US EVA suit used aboard the ISS. The Orlan (Eagle) -M suit, 
produced by NPP Zvezda, is the current Russian EVA suit and had been previously used 
aboard the Mir Orbital Station. The U.S. EMU suit consists of several layers including a 
polyurethane-coated nylon pressure layer, a polyester structural restraint layer, and a 
woven Kevlar®, Teflon®, and Dacron® anti-abrasion outer layer (Thomas, 2006). An 
estimated translation of this suits thickness to an equivalent Aluminum range based on 
previous studies (Benton, Benton, & Frank, 2001; Zeitlin et al., 2001) will be applied in 
this PHITS simulation. The aluminum thicknesses of 0.1 cm (.27 gm/cm2), 1 cm (2.7 
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gm/cm2), 5cm (13.5 gm/cm2) and 13.5 cm (36.45 gm/cm2) will be used to encompass a 
range of potential EVA and intravehicle shielding. Particle fluence inclusive of delta ray 
and fragmentation contributions and the dose corresponding to depth in the skin layers 
illustrated in Figure 11. will be tallied and applied to the MCDS model.  
 
 
Figure 11. Epidermal components to be simulated. Representation of arterial blood flow 
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2.4 Atmospheric Oxygen Transport to the Human Skin 
 
The mode of oxygen uptake to human tissue is generally considered to be via the 
lung and through the vascular system, but cutaneous uptake through the epithelium has 
been observed to significantly influence oxygen concentration in the skin (Stucker et al., 
2001).  Oxygen supply of the epidermal and dermal layers is a balance between oxygen 
transport by the blood and uptake from the atmosphere. The epidermis is avascular or 
contains no blood vessels and is nourished almost exclusively by diffused oxygen from 
the surrounding air, however cells in the deeper layers are nourished by diffusion from 
blood capillaries extending to the upper layers of the dermis.  The epidermis is 
composed of about 95% keratinocytes but also contains melanocytes, Langerhans cells, 
Merkel cells and inflammatory cells. Although not a direct indicator of inflammation, 
keratinocytes can modulate the immune system including providing cytokine stimulus of 
cutaneous inflammation via Langerhans cell activation via Interleukin-1 beta (IL-1β) 
secretion or Tumor Necrosis Factor alpha (TNFα) (Banno, Gazel, & Blumenberg, 2004). 
This is a notable endpoint due to the strong atmospheric influence and variability of 
epidermal oxygen tension. 
Cutaneous diffusion of oxygen occurs at varying levels in different locations. 
Oxygen diffusion in human anatomy is at highest rates through the eyelids  (.10 mm) 
(necessary for the cornea, which does not have a oxygen providing blood supply) and 
lowest through the thickest palms and soles (1.5 mm). These skin thicknesses were 
detailed as the target of the radiation transport model.  
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The common medical assumption is that inspired atmospheric oxygen (PIO2) is 
saturated with water vapor at body temperature is applied (Patm - 47 mmHg), resulting 
in an inspired oxygen pressure (PIO2) of around 150 mmHg. Inspired oxygen diffuses 
through the alveolar wall in the lungs then becomes bound to hemoglobin in addition to 
dissolving into plasma. Numerous factors determine the value of alveolar pressure of 
oxygen and carbon dioxide: pressure of the outside air (Patm), partial pressures of 
inspired oxygen (PIO2) and carbon dioxide (PICO2), rate of oxygen consumption, carbon 
dioxide production, and the rates of alveolar gas exchange. The average alveolar partial 
pressures for O2 (PAO2) and CO2 (PACO2) are about 100 mmHg (2.03 psi) and 40 mmHg 
(.77 psi), respectively. Equilibrium is readily met for CO2 between alveolar and arterial 
interfaces and therefore arterial CO2 (PaCO2) may be considered 40 mmHg as well.  
For dry air at sea level, the partial pressures for oxygen (PO2) and carbon dioxide 
(PCO2) are about 160 mmHg (3.09 psi) and 0.3 mmHg (.006 psi), respectively. The 
alveolar O2 partial pressure (PAO2) is not routinely measured but may be calculated from 
blood and gas measurements (such as pulse oximetry) using the standard alveolar gas 
equation (Equation 4). 
 
          
             Equation 4 
 
where R is the Respiratory Quotient (normally about 0.8 and approaching 1 for an all 
glucose diet), PAO2 is the alveolar partial pressure of O2,  PIO2 is the inspired partial 
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pressure of O2,  PACO2 is the alveolar partial pressure of CO2 and F is the correction 
factor (usually less than 2 mmHg (.04 psi) ).   
At the alveoli-arterial interface, the partial pressure of oxygen is relatively high, 
and oxygen binds readily to hemoglobin that is present. As the blood circulates to other 
body tissues where the partial pressure of oxygen is lower, oxygen is released into the 
tissue due to the lower concentration of oxygen present from metabolic consumption. In 
spaceflight, the most significant factor influencing oxygen-hemoglobin binding is 
atmospheric carbon dioxide, which varies depending on spaceflight activities and 
filtering specifications.  Carbon dioxide decreases the amount of oxygen that is available 
for binding for a given pO2. There is an additional environmental consideration due to 
temperature, but this is considered minimal compared to carbon dioxide influence 
(Fournier, 2007). 
The contribution of oxygen-hemoglobin binding is best illustrated by the oxygen-
hemoglobin saturation curve (Figure 12).  The oxygen-hemoglobin saturation curve 
relates oxygen saturation (SO2) and partial pressure of oxygen in the blood (pO2). 
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Utilizing the alveolar gas equation as an input for lung respiration, the oxygen 
tension boundary condition found in literature (Wang et al., 2003) and a comprehensive 
cardiorespiratory model, PNEUMA (Hsing-Hua & Khoo, 2002), oxygen tension was 
simulated across a range of epidermal thickness. The chosen respiratory model depicts 
numerous breathing cycles, inclusive of the rapid transients of spaceflight operations. 
The model is depicted in Figure 13.  
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Figure 13. Cardiorespiratory model, PNEUMA (Hsing-Hua & Khoo, 2002)
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The PNEUMA oxygen transport model has been benchmarked for hypercapnia, 
hypoxia, periodic breathing and moderate exercise with realistic trends against many 
alternatives (Cheng, Ivanova, Fan, & Khoo, 2010; Mananas et al., 2003). These 
situations encompass a range of breathing activities encountered in spaceflight. The 
model is divided into interconnected differential equations with sections for the alveolar 
space, body tissue, and central nervous system feedback mechanisms. Oxygen 
consumption and carbon dioxide production inclusive of the respiratory quotient as 
found in the alveolar-gas equation may be applied to input and outputs of this model. 
Inputs and output variables in the lung of this model are provided in Figure 14 and 15. 
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Figure 14. PNEUMA arterial and alveolar partial pressures associated with gas exchange 
in the lungs (Hsing-Hua & Khoo, 2002) 
 
In order to account for skin oxygen tension in epidermal layers, external 
boundary conditions of measured epidermis tension values were taken from literature 
(Evans & Naylor, 1967; Roszinski & Schmeller, 1995) (Wang et al., 2003) and internal 
dermal oxygen tension acquired from the cardiovascular models (Hsing-Hua & Khoo, 
2002) (Harada, Kubo, Mori, & Sato, 2005) were obtained and applied to the time 
dependent Fick’s Second Law (Equation 5)  
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      Equation 5 
 
where Oxygen concentration CO2 is expressed, as a function of linear distance X across 
the epidermis and CaO2 is the arterial concentration of oxygen (ml O2/100ml).  
The diffusion approximation provides that there is no oxygen flux at partial 
pressure equilibrium and experiments have validated this assumption. A minimum 
intracutaneous pO2 of 51 mmHg has been recorded for exposed skin (Evans & Naylor, 
1967; Roszinski & Schmeller, 1995). Other measurements with covered skin have pO2 
range from 8 to 35 mmHg or 1.1 to 4.6 % of 1 atm (Wang et al., 2003).     
The arterial concentration of oxygen (CaO2) is a standardized physiological 
quantity that reflects the volumetric amount of oxygen in tissue from dissolved oxygen 
and oxygen bound to hemoglobin (oxyhemoglobin) and is calculated in Equation 6.  
This arterial concentration will be provided by PNEUMA for various respiratory trials 






    
     
            
       
     
                   
     
               
      
                       
     
                     
Equation 6 
where Hb is the grams of Hemoglobin per 100ml of blood (usually 12-16), SaO2 is the 
percent arterial oxygen saturation of hemoglobin and PaO2 is the arterial oxygen tension. 
From this relationship it can be discerned, except for cases of anemia or hyperbaric 
oxygen treatment, that oxyhemoglobin is the most significant contributor of oxygen 
content in the blood and oxygen delivery to tissues.  
 The arterial concentration of oxygen (CaO2) is strictly a volumetric percent 
quantification of oxygen in blood. In order to provide inputs for oxygen concentration 
gradients and metabolic consumption a mass density or molar quantification is 
necessary. A single hemoglobin molecule contains four oxygen-bonding sites (Figure 
16).  Oxygen saturation, SO2 describes the percent of these binding sights occupied by 
oxygen and is approximately 100% in healthy individuals while in the arteries (SaO2) 
and decreasing as oxygen is deposited into tissues and blood enters the venous system. 
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Figure 15. PNEUMA outputs from 100% oxygen breathing at 1 atmosphere (760 
mmHg) at t=0. (Pressure of inspired oxygen PiO2 713mmHg) 
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Using the previously described hemoglobin density Hb, arterial oxygen saturation SaO2, 
and hemoglobin binding sights the molar density of oxygen may be obtained in 
hematocrit (packed red blood cell volume). In order to determine the molar density of 
oxygen in plasma, Henry’s Law may be applied (Equation 7). Summing both the 








             Equation 7 
 
where Cp is the concentration of oxygen, α is the solubility coefficient and PO2 is the 
partial pressure of oxygen. 
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2.5 Oxygen Dependence Simulation 
 
The exact mechanism of cell death and inflammation due to radiation exposure is 
still an area of active investigation.  A large body of evidence supports the initiation and 
processing of double-stranded breaks (DSB) in nuclear DNA as a primary factor in 
reproductive cell death (Carlson et al., 2008), although other interactions may be 
significant including that of non-targeted effects (NTE). In skin exposure, NTE manifest 
in deterministic fashion in response to cell death; ionizing radiation leads to 
accumulation of lymphocytes and macrophages in the layers of the skin and eventually 
leads to the development of erythematous skin changes (Peter, 2005).  
 There are several hypotheses which try to explain the Oxygen Enhancement 
Ratio (OER) in cellular processes in more detail (Masunaga et al., 2009; Michael & 
Prise, 1996; Stuglik, 1995; Ward, 1994) but to date there is no consistent theory that 
could explain the oxygen effect on a specific physical basis. In order to correlate the 
response of a biological system to radiation as a function of the oxygen partial pressure 
pO2, a correlation termed relative radiosensitivity (RR) was developed by Alper (Alper 
& Howard-Flanders, 1956). Utilizing this correlation, the survival of cells irradiated 
under varying oxygen concentrations are well approximated by a modified linear-
quadratic (LQ) cell survival model (Stewart et al., 2011), i.e., the fraction S of the cells 
surviving absorbed dose D is shown in Equation 8. Here, α and β characterize intrinsic 
cellular radiation sensitivity dependent on oxygen and G is the dose protraction factor.  
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S= e(–α*D – β*G*D^2)    Equation 8 
  
In the linear-quadratic model, two components of cell injury are present. The 
linear α component is responsible for the initial shoulder on the cell survival curve and is 
caused by general single detriment repairable damage to the DNA. The quadratic E  
component represents multiple detriments to the DNA with a G protraction or repair 
factor. The linear component is proportional to the dose, whereas the quadratic 
component is proportional to the dose squared.  
Early-responding tissues and tumors have a relatively larger alpha component 
and a larger α/β ratio; late-responding tissues have smaller α/β ratios (Halperin, Perez, & 
Brady, 2008). Values of α/β for early onset erythema vary from 8-11 Gy and for 
desquamation 11-12 Gy. These features are incorporated into the correlation of 
deterministic effect in this model.  
Methods to correlate DNA DSB probability with radiation track structure exist 
with reliable verification (Costes et al., 2007; Hauptner et al., 2006). Predicted trends in 
the DSB induction are consistent with estimates derived from measured data for DSB 
induction and cell survival curves (Carlson et al., 2008; Stewart et al., 2011).  
 A comprehensive microdosimetric transport software package, Monte-Carlo 
Damage Simulation (MCDS) (Stewart et al., 2011) simulates incident ion track structure 
and utilizes oxygen fixation as an indicator of DNA radicals removed through the 
chemical repair processes. In this procedure, the relative radiosensitivity (RR) equation 
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developed by Alper and Howard-Flanders (Alper & Howard-Flanders, 1956) is modified 
for use in the oxygen fixation DNA repair mechanism. This enables a direct correlation 
of oxygen dependence and DSB incidence with cell survival curves. A sample output of 




Figure 17. MCDS simulations of OER vs LET by particles type (Stewart et al., 2011). 
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3. RESULTS AND DISCUSSION 
 
3.1 Solar Particle Transport and Energy Deposition in Matter 
  
As the primary source particle in SPEs, protons directly contribute the largest 
portion of SPE dose to the skin. Secondary interaction and fragmentation may result in 
significant exposure contribution depending on variables inclusive of energy and 
material thickness. For the estimation of proton dose alone, the Bethe stopping power 
Formula in Equation 9 may be utilized. Variable values are provided for a water target.  
 
L = .307 (Zt ρ/At) (Zp2/β2) (ln(2 me β2/(I (1 - β2))) - β2)  Equation 9 
 
Zt – Atomic Number of the Target Material: 10 
At – Mass Number of the Target Material: 18 
me – Electron Mass: .511 MeV 
I – Mean Excitation Potential: 74.9x10-6 MeV 
ρ – Target Material Density: 1 gm/cm3 
Zp – Atomic Number of Incident Particle: 1 
β – (particle velocity)/(speed of light) 
 
Significant exposure to neutrons may result from nuclear interactions that 
increase with the amount of material utilized for shielding (Table 3). Additionally, 
fragmentation is a notable occurrence for high-energy interaction on target surfaces. At 
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aluminum thicknesses greater than 5 cm, neutrons may comprise 5% or more of the total 
particle flux. These attributes with the variability of radiation quality, make accounting 
for particle types prudent for making accurate estimates of dose and resultant biological 
effect. 
 




Thickness of Aluminum 
(cm) (density = 2.7 gm/cm3) Particle 
% of Fluence 
PHITS Transport 
Calculation 




















Table 3. Total particle flux percent for the August 1972 SPE transported by 
PHITS vs. aluminum thicknesses of 0.1, 1, 5 and 13.5 cm (density = 2.7 gm/cm3) 
 
PHITS provides dose and flux tallies normalized to the particle source or source 
flux, if applicable, in units of (MeV/Source) for t-deposit and (1/cm2/Source) for t-track 
and t-cross. T-cross is used exclusively for flux or current crossing a surface, while t-
track is sum of track lengths (cm) that intersect a defined volume. Since the flux t-cross 
tally is evaluated with weight of 1/cos θ, the result is equivalent to that obtained from the 
[t-track] tally for an extremely thin region. This assumption is useful for simulating 
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transport through thin layers of skin or shielding. However for purposes of extendibility 
macroscopic volumes are assumed as a baseline assumption, therefore the t-track tally is 
used for flux attribution within material volumes. 
This normalized output is useful to examine the relevance of energy distribution 
for deposition and transport through matter. Spectra weighted towards higher energy, 
such as the 1956 SPE distribution (J. W. Wilson, 1976) result in greater energy 
deposition at increasing depth (Figure 18).  
 
 
Figure 18.  Flux normalized energy deposited as a function of depth with 5 gm/cm2 of 
aluminum equivalent shielding from 1956, 1960, 1972, and 1989 SPEs. Energy absorbed 
is represented in aluminum for z < = 1.85 and water for z  > 1.85 cm. 
 
In order to correctly represent the total absorbed dose of a respective SPE, these 
PHITS outputs must be scaled to their respective particle flux (Table 4).  A script was 
written in MATLAB® in order to properly attribute and generate data for comparison 
cm
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(Appendix B.1). The units of MeV/Source are weighted by source flux with resultant 
units of MeV/cm2. 
 
SPE Event Date Data Source 
Total Source Particle Flux 
cm-2 
February 1956 NASA Langley (Wilson) ϕ=2.52E+09 
 
Webber ϕ=1.01E+10 
November 1960 NASA Langley (Wilson) ϕ=1.79E+10 
August 1972 NASA Langley (Wilson) ϕ=1.76E+10 
 
King ϕ=2.33E+10 
October 1989 NASA Langley (Sauer) ϕ=5.21E+10 
September 1989 NASA Langley (Sauer) ϕ=1.41E+10 
Table 4.  Total particle flux for selected SPE data sets 
 
 
From the five SPEs simulated, total dose for a range of shielding thicknesses 
indicate the August 1972 event to be of most concern for the selected shield thicknesses 
and consideration of dermis and epidermis dimensions (Figure 19). This is despite a 
higher overall flux is attributed to the October 1989 event. Prior publications have 
verified this result (Figure 20).  
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Figure 19. Energy deposited as a function of depth with 5 gm/cm2 of aluminum 
equivalent shielding from 1956, 1960, 1972, and 1989 SPEs. Energy absorbed is 




Figure 20. Comparison of the predicted skin dose rates for the August 1972 and 
October 1989 SPEs as a function of time since event onset and behind 2 g/cm2 
aluminum shielding (Parsons & Townsend, 2000). 
 
cm
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Comparing the energy spectrums from the August 1972 and October 1989 SPE 
differential spectrums, it can be discerned that the August 1972 event has significantly 
greater flux component from energies 30 MeV to 150 MeV. This difference in energetic 
flux is most pronounced in the data reported by (King, 1974) (Figure 21). 
 
 
Figure 21. Comparison of energy differential particle fluence for the August 




However, due to the lesser amount of flux at energies above 150 MeV from the 
August 1972 SPE, energy deposition decreases below that of other SPE at several 
centimeters of depth (Figure 22 - 5 gm/cm2). It should also be noted that as the thickness 
of the aluminum shield increases, a decrease in flux and energy deposition from August 
1972 SPEs below that of other SPEs occurs (Figure 23 - 12.9 gm/cm2 and Figure 24 - 0.2 
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gm/cm2 ). This is physically explained by the reduction in greater penetrating higher 
energy flux from the increase in aluminum shielding.  
 
 
Figure 22. Energy deposited as a function of depth with 5 gm/cm2 of aluminum 
equivalent shielding from 1956, 1960, 1972, and 1989 SPEs. Energy absorbed is 
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Figure 23. Energy deposited as a function of depth with 12.5 gm/cm2 of 
aluminum equivalent shielding from 1956, 1960, 1972, and 1989 SPEs. Energy absorbed 






Figure 24. Energy deposited as a function of depth with 0.2 gm/cm2 of aluminum 
equivalent shielding from 1956, 1960, 1972, and 1989 SPEs. Energy absorbed is 
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For the selected shield thicknesses and consideration of dermal and epidermal 
dimensions, the energy deposited by SPEs like August 1972 and October 1989 SPEs are 
most indicated to initiate deterministic effect to the skin. Therefore, these specific 
datasets will be utilized for MCDS simulation.  
 
3.2 Particle Flux Incident on Skin 
 
The MCDS code is a Monte Carlo and microdosimetric simulation that attributes 
energy deposition within a cellular volume from incident particle energy fluence. 
Therefore, it is prudent that incident flux is utilized to allow for the microdosimetric 
calculations. Future revisions of this work may seek to integrate the microdosimetric 
capabilities of PHITS with the [t-sed] tally.  
Incident fluxes on skin were estimated from PHITS with aluminum shields of 
0.1, 1, 5 and 13.5 cm at a density of 2.7 g /cm3. For the U.S. EMU, aluminum equivalent 
thicknesses of 0.1 and 5 cm are most descriptive of EMU shielding (Zeitlin et al., 2001) 
while thicknesses greater than 1 cm are common in spacecraft. Expectedly, proton fluxes 
decreased as shielding increased. This result may be viewed in Figures 25, 26, 27 and 
28. 
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Figure 25. Proton flux as a function of energy behind 0.1 cm (0.27 gm/cm2 ) of 





Figure 26. Proton flux as a function of energy behind 1 cm (2.7 gm/cm2 ) of 
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Figure 27. Proton flux as a function of energy behind 5 cm (13.5 gm/cm2 ) of 





Figure 28. Proton flux as a function of energy behind 13.5 cm (36.5 gm/cm2 ) of 
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The 1972 SPE events maintain a higher flux distribution below 150 MeV 
however, as shielding increases beyond 5 cm standard aluminum equivalent thickness, 
the 1989 SPE event indicates higher overall flux. This decrease in the 1972 SPE proton 
flux is associated with significant dose attribution from proton energies less than 150 
MeV. This is notable since to the typical thickness of EVA shielding is less than 5 cm. 
This proton interaction in aluminum equivalent shielding also gives rise to a 
number of secondary interactions and particles most notably neutrons, electrons and 
alpha particles. Neutron generation is shown in Figures 29, 30, 31 and 32. Neutrons 
interact primarily with recoil collisions or absorption and the resultant localized energy 
deposition can be much higher than the incident proton spectra as well as give rise to 
even more secondary particles.  
 
 
Figure 29. Neutron flux as a function of energy behind 0.1 cm (0.27 gm/cm2 ) of 
aluminum equivalent shielding for 1972, and 1989 SPEs.  
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Figure 30. Neutron flux as a function of energy behind 1 cm (2.7 gm/cm2 ) of 




It can be readily discerned that a minor increase of shielding from 0.1 cm to 1cm 
results in a significant increase of neutron flux across much of the lower energy range up 
to 150 MeV. The lower weighted energy of the neutrons is significant since this is 
indicates a higher likelihood of localized energy deposition in the surrounding media. 
This energy deposition can be observed in Figures 31 and 32.  
Energy (MeV)
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Figure 31. Neutron flux as a function of energy behind 5 cm (13.5 gm/cm2 ) of 





Figure 32. Neutron flux as a function of energy behind 13.5 cm (36.5 gm/cm2 ) of 
aluminum equivalent shielding for 1972, and 1989 SPEs.  
Energy (MeV)































  52 
Further increases in shielding drastically remove low energy neutrons as they are 
generated in the aluminum shielding. The resultant energy deposition can be discerned 
via electron flux and to a lesser extent from nuclear interaction that produces alpha 
particles. This resultant increase in electron flux inclusive of delta ray contribution as 
shielding thickness increases can be seen in Figures 33, 34 and 35.  
 
 
Figure 33. Electron flux as a function of energy behind 0.1 cm (0.27 gm/cm2 ) of 
aluminum equivalent shielding for 1972, and 1989 SPEs.  
Energy (MeV)
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Figure 34. Electron flux as a function of energy behind 1 cm (2.7 gm/cm2 ) of 





Figure 35. Electron flux as a function of energy behind 5 cm (13.5 gm/cm2 ) of 
aluminum equivalent shielding for 1972, and 1989 SPEs.  
Energy (MeV)
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In Figure 35 the electron flux at 5 cm shielding thickness appears to have 
reduced slightly from that of 1 cm shielding thickness. This is indicative of reduction of 
primary incident flux and overall reduction in energy deposition. Similarly, the 
generation of alpha particle flux from pathways such as high-energy fragmentation on 
the shielding surface and subsequent nuclear interaction such as from neutron absorption 
substantially decreases as shielding thickness increases. Alpha fluxes are shown in 
Figures 36 and 37. 
 
 
Figure 36. Alpha paticle flux as a function of energy behind 0.1 cm (0.27 
gm/cm2) of aluminum equivalent shielding for 1972, and 1989 SPEs.  
 
Energy (MeV)













  55 
 
Figure 37. Alpha particle flux as a function of energy behind 1 cm (2.7 gm/cm2 ) 




These respective particle fluxes of all simulating shielding thicknesses are 
applied to the MCDS model with a dependent oxygen concentration based on the 
proceeding physiological simulation.  
 
3.3 Oxygen Tension in Epidermal Layers 
 
Oxygen tensions in epidermal layers were simulated for three skin thicknesses: 
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Epidermal Size Thickness Anatomy 
Thin 0.005 cm Eyelids 
Average 0.01 cm Shoulder, Forearm 
Thick .15 cm Palm, soles 
Table 5. Epidermal simulation thicknesses 
 
It is assumed the stratum corneum has a constant thickness of 15 μm and stratum 
basal, stratum spinosum and stratum granulosom layers evenly divide the remainder 
thickness. Under normal conditions the upper skin layers are supplied exclusively by the 
diffusion of oxygen from the atmosphere.  
The application of Fick’s First Law yields oxygen flux, J and partial pressure of 
O2 at position x in a single directional gradient under the steady state assumption 
Equation 10 and 11. 
 
                 Equation 10  
       
   
        Equation 11 
 
The oxygen permeabilities, K may be assumed from literature as 3.7 x 10-7 (ml 
O2 ) / (m min Torr) in the stratum corneum and 1.3 x 10-6 (ml O2 ) / (m min Torr) in viable 
tissue (Huch & Lubbers, 1981).  While the permeability coefficient is proportional to the 
diffusion coefficient, it is traditionally independent of certain quantities, such as 
thickness, x which is significant due to the oxygen consumption and diffusion dynamic 
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through tissue layers. In order to maintain standardized units a diffusion constant, D is 
used in lieu of permeability constant (Table 6).  
 In compliance with Fick’s First Law there is no oxygen flux, J between the 
upper layer PO2 and the skin tissue below the point at which the minimum oxygen 
tension is reached. Tissue beneath this minimum is exclusively provided oxygen by the 
cardiovascular system. This necessitates numerous boundary conditions to accommodate 
skin layers and direction of oxygen transients. The boundary conditions for elimination 
of oxygen flux, flux continuums between stratum corneum, stratum granulosum, stratum 
spinosum and basal layer are presented in Equation 12,13,14, 15 and 16.  
 
  
                              Equation 12 
                                                Equation 13 
                                                Equation 14 
                                                Equation 15 
                                           Equation 16 
 
As oxygen diffuses across a thickness x, concentration (or partial pressure) will 
change unless continuous gradient is maintained. For the transients associated with space 
travel, this necessitates tracking of changes in this gradient as a function of time.  
 The time dependent Fick’s Second Law may be arranged to equate volumetric 
oxygen consumption across layers as a function of time, V resulting in an 
Inhomogeneous second-order Partial Differential Equation (PDE). This may used to 
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          Equation 17 
 
where the concentration of oxygen is C (ml O2/100ml ) 
Average oxygen consumption, V has been measured and published in literature 
(Table 6).  However, in the dead skin layer, or stratum corneum there is no oxygen 
consumption (V = 0) and this results in a homogenous differential equation.  
 
Variable Value 
V – Living Epidermis 1990 ml O2 m-3 min-1 (1) 
 V – Stratum Corneum 0 
V – Dermal Tissue 1470 ml O2 m-3 min-1 (1) 
D - Epidermis 1 x 10-6 cm2 s-1 (2) 
D - Stratum Papillare Tissue (Dermis) 1.5 x 10-5 cm2 s-1  (2) 
Co – Epidermal Oxygen Solubility 8.9 nmol ml-1 kPa-1 (3) 
Co – Epidermis (Normoxic) at surface 189.85 nmol ml-1 ; 0.18995 mM (3) 
Table 6.  Constants utilized in the oxygen diffusion simulation. 1) (Evans & Naylor, 
1967) 2) (Grossmann, 1982; Talbot, Neuman, Saidel, & Jacobsen, 1996) 3) (Siggaard-
Andersen, Wimberley, Göthgen, & Siggaard-Andersen, 1984; Talbot et al., 1996) 
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Solving this equation for oxygen concentration under the steady state assumption as a 
function of depth C(x) in a single oxygen gradient yields (Equation 18): 
 
             
            Equation 18 
 
A minimum intracutaneous pO2 of 51 mmHg has been recorded to exposed skin 
(Evans & Naylor, 1967; Roszinski & Schmeller, 1995). Other measurements with 
covered skin have pO2 range from 8 to 35 mmHg or 1.1 to 4.6 % of 1 atm (Wang et al., 
2003).  The resulting constants c1 and c2 may be solved by boundary condition 
associated with epidermal and dermal layers.  
This description is problematic in that it assumes constant consumption, Vi 
throughout the cellular volume. Experimentation has confirmed that oxygen 
consumption is dependent on oxygen concentration in living cells due to adaptive 
metabolic processes (Bingmann & Kolde, 1982).  To better account for this effect 
Michaelis–Menten kinetics with origin in enzyme reaction rates was utilized in all cell 
layers accept for the stratum corneum, whereas no consumption is assumed.  
Michaelis-Menten kinetics relates the reaction rate, Vo to C, the concentration of 
a substance. This correlation has multiple uses for biochemical processes and is a 
component of oxygen fixation hypothesis within the MCDS code. Substituting the 
reaction rate, V (Equation 19) in the time-dependent differential equation for these 
kinetics results in second-order non-linear PDE presented in Equation 20.  
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                                             Equation 19    
  
     
   
     
         
                              Equation 20    
 
where Vo is the maximum rate of oxygen consumption and Ko is the concentration of 
oxygen at one-half maximum rate. In order to define constants Vo and M published 
values as measured in literature were utilized (Table 7) 
 
Variable Value 
Vo   .059 nmol/ml-s 
Ko  .075 nmol/ml 
Table 7. Oxygen consumption parameters as applied to Michaelis-Menten kinetics (McGoron, 




Normoxic and hyperoxic induction simulations provided by PNEUMA and pre-
defined constants (Appendix C) results in minimally different steady state arterial 
oxygen content, CaO2. However, this transient is significant enough to shift the oxygen 
concentration in skin by an observable amount. Converting CaO2, a volumetric quantity 
into molar density for oxygen gradient equations requires a density conversion for blood 
as well as molar density for oxygen for both hemoglobin and dissolved oxygen 
contributions. Fortunately, the density of blood has negligible dependence from oxygen 
and carbon dioxide content. In order to standardize output a constant hemoglobin 
concentration will be utilized. 
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A blood density of 1060 kg /m3 (1.060 gm/cm3) (Shmukler, 2004) and the 
molecular weight of hemoglobin is established as 64450 g/mol with minimal variation 
(Van Beekvelt, Colier, Wevers, & Van Engelen, 2001). The hemoglobin density in blood 
is chosen as 150 g/L based on ranges for males of 140 to 180 g/L and for females of 120 
to 160 g/L (Billett, 1990). The resultant hemoglobin concentration based on these values 
is 2.3 mM (millimol / L). 
Concentration of dissolved oxygen can be calculated using Henry’s Law 
(Equation 7). Where Cp is the concentration of oxygen, α is the solubility coefficient and 
PO2 is the partial pressure of oxygen. The solubility constant has been published in 
literature (Valabrègue, Aubert, Burger, Bittoun, & Costalat, 2003) as 1.39 x 10-3 
mM/mmHg. The resultant range of arterial oxygen concentration is presented in Figures 
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Figure 38. Normoxic breathing at 1 atmosphere (760 mmHg) at t=0. (Pressure of 
inspired oxygen PiO2 150 mmHg). Steady state CaO2 is 20.1% (20.1 ml O2/100ml), SaO2 
is 98.25% and PaO2 is 104.5 mmHg. The resultant oxygen concentration is (2.3 mM x 4 





Figure 39. Hyperoxic (100% O2) breathing at 1 atmosphere (760 mmHg) at t=0. 
(Pressure of inspired oxygen PiO2 713 mmHg). Steady State CaO2 is 20.4% (20.4 ml 
O2/100ml ), SaO2 is 99.985% and PaO2 is 670 mmHg. The resultant oxygen 





The oxygen concentration from these simulations may be utilized in a boundary 
condition (Equation 21) at the basal layer and dermis, coincident with the arterial 
capillary blood supply.  Utilizing the boundary conditions within the epidermis 
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(Equations 11-15) and oxygen diffusion and consumption relation (Equation 19) an 
overall oxygen transient gradient may be obtained.  
                 
              9.18 mM to 10.13 mM    Equation 21 
 
As expected, the presence of hemoglobin allows for a much greater concentration 
of oxygen versus that from the partial pressure of oxygen dissolved in tissue. In the 
macroscopic scenario, this results in a reserve of oxygen greater than metabolic 
requirements for a human at-rest (Lundsgaard, 1919). 
The introduction of Michaelis-Menten kinetics into the diffusion approximation 
results in a non- linear piecewise second-order PDE and a substantial increase in 
complexity in obtaining a unique analytical solution. Similar solutions have been 
published in literature (Bassom, Ilchmann, & Voß, 1997) for uniform geometry and 
without broad applicability. Due to this complexity a numerical solution is pursued for 
the defined scenarios.  
Oxygen concentration gradients were obtained via numerical approximation with 
Mathematica software with the supplied boundary conditions. An example of this code 
may be found in Appendix B.3. 
Simulations for both thin (.005 cm) and medium (.01 cm) skin thicknesses 
indicate little variation in the oxygen transient (Figures 40 and 42). It is observed that 
with the lack of oxygen consumption in the stratum corneum, oxygen concentration 
transients progress slightly faster. For both simulations a steady state is reached within 
64 
seconds. The most significant difference between thin and medium skin thicknesses may 
be found between the top layers of skin (Figure 41 and 43).  
Figure 40. Oxygen concentration gradient from a thin skin surface with 100% 
oxygen breathing at 1 atmosphere (760 mmHg) from t=0. (Pressure of inspired oxygen 
PiO2 713mmHg) 
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Figure 41. Detailed view of the oxygen concentration gradient from a thin skin 
surface with 100% oxygen breathing at 1 atmosphere (760 mmHg) from t=0. (Pressure 





Figure 42. Oxygen concentration gradient from a medium thickness skin surface 
with 100% oxygen breathing at 1 atmosphere (760 mmHg) from t=0. (Pressure of 
inspired oxygen PiO2 713mmHg) 
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Figure 43. Detailed view of the oxygen concentration gradient from a medium 
thickness skin surface with 100% oxygen breathing at 1 atmosphere (760 mmHg) from 
t=0. (Pressure of inspired oxygen PiO2 713mmHg) 
 Consideration of the thickest epidermal layers, such as the soles and palms can be 
observed to yield a significantly different oxygen concentration gradient. In can be 
concluded in this anatomy that the significance of oxygen diffusion may be greater due 
to the greater diffusion distance from the arterial capillary oxygen supply. Boundary 
condition transients are not observed to reach a steady state until several minutes have 
elapsed (Figure 44 and 45). 
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Figure 44. Oxygen tension gradient from a thick skin surface with 100% oxygen 






Figure 45. Detailed view of the oxygen tension gradient from a thick skin surface 
with 100% oxygen breathing at 1 atmosphere (760 mmHg) from t=0. (Pressure of 
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The relatively greater oxygen concentration in deeper skin layers is associated 
with the high oxygen carrying capacity of hemoglobin. This concentration is about 3-4 
times the amount of oxygen required for a resting metabolic state(Lundsgaard, 1919).  It 
additionally enables some brief metabolic exertion prior to the cardiovascular system 
accommodating a change in oxygen consumption.  
  The resultant steady-state curves are established in a few seconds for thin and 
medium epidermal thicknesses and several minutes for thick epidermal thicknesses. The 
curves are provided in Figure 46. 
 
 
Figure 46. Steady-state oxygen concentration gradient from a thin, thick and 
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In order to demonstrate the transient from a normoxic environment to a 
hyperoxic environment as associated with EVA activity the following simulation is 
provided with a transition from normoxic to hyperoxic environment at t = 540s (Figure 
47). This results in a slight increase in concentration values that are more pronounced in 




Figure 47. Oxygen concentration gradient from a thick skin surfaces with initial 
21% oxygen breathing at 1 atmosphere with a transition to 100% oxygen breathing (760 




In order to demonstrate broader application of this diffusion model, an example 
of terminating arterial blood supply is provided in Figure 48. It can be readily observed 
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Figure 48. Oxygen concentration gradient from a thin skin surfaces at 21% 
oxygen breathing at 1 atmosphere (760 mmHg) with a termination of arterial blood 




To properly relate the oxygen concentration or solubility in tissue to the MCDS 
code a correlation is needed in atmospheric content. Using Henry’s law again for tissue 
and associated solubility constant (Table 6) instead of plasma as calculated previously 
will yield an equivalent atmospheric pressure for tissue. This relationship utilized with 
the preceding oxygen concentration simulations can be used to reveal that the partial 
pressure of oxygen in tissue.  
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4. SUMMARY AND CONCLUSIONS 
 
4.1 Hypoxic Reduction Factor and Resultant Biological Effect 
 
Due to the intended comparison of the RBE for hypoxic versus normoxic tissue, 
the output of the MCDS code defines and provides a Hypoxic Reduction Factor (HRF) 
in lieu of OER. OER has been used extensively as a scaling factor with variable oxygen 
concentrations against a hypoxic condition that may produce trends counter to those 
associated with a normoxic test environment. The HRF is defined as the ratio of the 
absorbed dose required to produce biological effect under hypoxic conditions to the 
absorbed dose required to produce the same effect under normoxic (21% O2 @ 1 atm) 
conditions. MCDS defines the HRF by Double Strand Break (DSB) induction and can be 
expressed as a ratio of doses or as ratio of DSB yields  
 
       
             
                  
   Equation 22 
 
MCDS does not provide for the alteration of normoxic oxygen tension, limiting 
application for hyperoxic simulation. This is particularly relevant for the skin epidermis 
that is normally hypoxic and EVA preparation activities where inspired oxygen (PIO2) 
may approach 713 mmHg (100%) at 1 atm. To account for this Relative Biological 
Effect (RBE) a baseline HRFSkin-Normoxic trend is produced that is representative of the 
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oxygen tension profile in the epidermis under atmospheric normoxic conditions (21% 
O2, 1 atm).  Another HRF can be produced for the representative epidermal oxygen 
tension profile under atmospheric transient HRFO2 Skin-Transient (i.e. 100% O2, 1 atm). The 
resultant RBESkin-Transient may be produced by dividing the HRFO2 Skin-Transient by HRFSkin-
Normoxic as shown in Equation 22. 
 
                  
                    
                 
   Equation 23 
 
The resulting flux averaged HRFs for all SPEs and shielding vs environmental 
oxygen partial pressure is presented in Figure 49. 
 
 
Figure 49. Flux-averaged HRFs for all SPEs and shielding thicknesses versus oxygen 
partial pressure present in tissue.  
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The resulting averaged HRFs for all simulated runs resulted in only minimal 
differences between all SPEs and vehicle shielding. As expected, a strong dependence 
on oxygen content is present. Under further examination slight differences due to SPE 
and shielding amount may be found (Figure 50 and 51). This is largely due to the 
continuous weighting towards proton flux despite significant contributions from 




Figure 50. Exploded view of flux-averaged HRFs for all SPEs and shielding thicknesses 
versus oxygen partial pressure.  
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Figure 51. Exploded view of flux-averaged HRFs for all SPEs and shielding thicknesses 




 The MCDS code utilizes atmospheric oxygen content as correlated to in vitro 
cellular studies and not tissue concentration directly. Taking into account the preceding 
section on oxygen concentration to tissue and correlating this to equivalent atmospheric 
oxygen pressure simply using Henry’s Law a correlation can be made.  
In the normoxic environment simulation (21% O2 at 1 atmosphere), thin and 
medium epidermal skin thicknesses produce HRFs near unity that ranges between .91 
and 1.02 (Figure 52). The stratum corneum, which has no oxygen consumption and is 
composed of non-proliferating cells, shows a significant hypoxia driven HRF up to 1.02. 
Conversely, the interior epidermis produces HRFs slightly less than 1 indicating more 
oxygen abundance than at a normoxic atmospheric. With the exception of the stratum 
Oxygen Atmospheric Pressure (mmHg)
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corneum, this is indicative that hemoglobin arterial supply provides more oxygen 
concentration in these tissues than a standard in vitro normoxic cell culture. Proper 
significance of the HRF in the stratum corneum, which has largely negligible 
susceptibility to DSB detriment, needs more radiobiology studies that perhaps tie in 
bystander effects and incorporate immune system response.  
 
 
Figure 52. HRF gradient for thin and medium thickness epidermal skin under normoxic 




The thick epidermal layers provide a significantly different normoxic HRF trend 
(Figure 53). The much greater diffusion depth associated with these thick layers creates 
a significant hypoxia away from atmospheric and arterial oxygen supply. As expected, 
the HRFs near the atmosphere (stratum corneum) and arterial supply (basal layer) are 
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Figure 53. HRF gradient for thick epidermal skin under normoxic (21% O2 at 1 




Hyperoxic simulations (100% O2 at 1 atmosphere) provide similar trends yet at 
slightly lesser magnitudes of HRF (Figures 54). It is significant to note that this 
difference is very pronounced in the normally hypoxic stratum spinosum and stratum 
granulosom thick epidermal sizes (Figure 55). 
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Figure 54. HRF comparison gradient between normoxic and hyperoxic conditions for 






Figure 55. HRF comparison gradient between normoxic and hyperoxic conditions for 
thick epidermal skin. 
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The previously defined RBEskin-transient provides a method for quantification of this 
change in RBE. For thin epidermal skin simulations, RBEskin-transient is below 1 and 
decreases down to .988 near the arterial blood supply. In medium epidermal skin 
thicknesses, RBEskin-transient is above 1 in the stratum corneum but decreases below 1 
towards .98 near the arterial blood supply (Figure 56).  Overall, the smaller thicknesses 
in the thin and medium sized epidermal simulation do not allow for high amount 
diffusion and thus limit the effect any environmental oxygen transient.  
 
 
Figure 56. Transient Relative Biological Effect (RBEskin-transient) for thin and medium 
thickness epidermal skin. 
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In the thick epidermal simulation diffusion is significant as previously indicated 
hypoxic trends illustrate. The RBEskin-transient has its greatest significance in these hypoxic 
regions of the stratum spinosum and stratum granulosom (Figure 57).  
 
 




 The overall results of these simulations indicate that hypoxic areas (relative to in-
vitro cell culture) are most affected by oxygen environment transients. However, the 
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significance of this occurrence is limited primary to the thickest epidermal skin surfaces 
such as the sole and palm. 
 
4.2 Discussion and Relevance for Space Mission Architecture  
 
The normally prevalent hypoxia in the epidermis results in decreased RBE 
relative to normoxic tissue, but is modifiable in certain anatomy in this model through 
oxygen variation in spaceflight. The significance of this modification appears to be 
limited only to the most hypoxic skin tissues that are the thickest and subsequently have 
the greatest amounts of diffusion. Consequently, the broad application to skin dosimetry 
has minimal RBE. 
All amounts of spacecraft shielding do not appear to result in significant 
modification in RBE and oxygen dependence due to shift in spectral LET. Further 
investigation with high-energy GCR may provide some significance due to a more 
significant secondary radiation contribution.  
Investigation with alternative anatomy may prove significant for space 
architecture, particularly in tissues with minimal vasculature or have significant variation 
in hemoglobin content. For example, the cerebral regions of the brain for example are 
known to contain about 2/3 less hematocrit than the arterial blood supply (Wyatt et al., 
1990). This is conjunction with ongoing research about Central Nervous System (CNS) 
effects from GCR (NCRP, 2006) could prove very significant.  
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4.3 Future Work and Additional Applications 
 
This model simulates DSB incidence and applies equal significance to all of the 
skin cell layers presented. However, this is not accurate since it is known rapidly 
proliferating epidermal stem cells occupy the basal layer, a host of lymphocytes and 
other immune cells often penetrate the epidermal layers in response to inflammation and 
serve as significant modifiers of RBE. Modification of this model to produce RBE that 
utilizes tissue dependent cellular kinetics, inclusive of immune response is a potential 
pursuit. Numerous studies (Cengel, Diffenderfer, Avery, Kennedy, & McDonough, 
2010; Shaowen Hu & Cucinotta, 2012; S. Hu et al., 2009; Jenine K. Sanzari et al., 2015; 
J. K. Sanzari et al., 2013; J. M. Wilson et al., 2011; Zhou et al., 2014) have already 
examined the cellular kinetics of SPEs to skin. Due to the presence of immune cells in 
the epidermis the skin is recognized as a marker for Acute Radiation Syndrome (ARS) 
particularly where the hematopoietic system is of concern.  
In medical applications, this model may serve to predict the appropriateness of 
dose in radiotherapy where hypoxia is a concern and oxygen prescription is 
administered. Additionally, it may be utilized as an aid to verification oxygen content 
with medical imaging modalities such as F-MRI, Blood Oxygen Level Dependent 
(BOLD) MRI or Dynamic Contrast Enhances (DCE) MRI. 
In the low dose application, there is greater difficulty in establishing correlation 
between stochastic effects to skin and ionizing radiation exposure.  A long-term study 
(Roy E. Shore, Albert, Reed, Harley, & Pasternack, 1984; R. E. Shore et al., 2002) 
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correlated 100 kVp x-rays to the scalp with increased incidence of basal cell carcinoma 
(BCC) with minimal correlation to squamous cell carcinoma (SCC) and 
indistinguishable attribution to melanoma. However, studies from (Fink & Bates, 2005) 
suggest a positive correlation between ionizing radiation and melanoma risk. The 
discrepancies in correlation lay in part to the large individual variat ions in ultraviolet 
sunlight exposure and melanin content among other radiosensitivity factors and the 
commonly unreported incidence of the largely non-fatal BCC and SCC. Although 
melanoma is the least prevalent form of skin originating cancer, it has the highest 
probability of metastasis and 75% of the attributable fatalities from skin cancer (Jerant, 
Johnson, Sheridan, & Caffrey, 2000). Reflecting the combined low mortality rate of 
SCC and BCC the International Council on Radiation Protection (ICRP) publication 60 
and 103 (ICRP, 2007) recommend a relatively low normalized radiation-weighting 
factor of .01 to skin.  
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APPENDIX A. SOLAR PARTICLE EVENT SPECTRA 
 
 
February 1956 SPE Integral Flux. Data obtained from (J. W. Wilson, 1976) 
 
 
 February 1956 SPE Integral Flux. Data obtained from (Webber, 1963) 
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November 1960 SPE Integral Flux. Data obtained from (J. W. Wilson, 1976) 
 
 
August 1972 SPE Integral Flux. Data obtained from (J. W. Wilson, 1976) 
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Figure X. August 1972 SPE Integral Flux. Data obtained from (King, 1974) 
 
 
September 1989 SPE Integral Flux. Data obtained from (Sauer, 1990) 
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APPENDIX B. UTILIZED CODES AND SCRIPTS 
 
B.1 MATLAB Total Flux Scaling Code 
 
 
function fluxsource = sourceselecter(midmid, midmidmid) 
  
fluxsource=0; %% particles/cm2 
  
if strcmp(midmidmid,'1956') 
    if strcmp(midmid,'Wilson') 
        fluxsource= 2.52E+09   ; 
    elseif strcmp(midmid,'Webber') 
        fluxsource= 1.01E+10; 
    else 
        msgbox('error2') 
    end 
elseif strcmp(midmidmid,'1960') 
    if strcmp(midmid,'Wilson') 
        fluxsource= 1.79E+10; 
    else 
        msgbox('error3') 
    end 
elseif strcmp(midmidmid,'1972') 
    if strcmp(midmid,'Wilson') 
        fluxsource=  1.76E+10; 
    elseif strcmp(midmid,'King') 
        fluxsource= 2.33E+10; 
    else 
        msgbox('error4') 
    end 
elseif strcmp(midmidmid,'1989') 
    if strcmp(midmid,'Sep') 
        fluxsource= 1.41E+10; 
    elseif strcmp(midmid,'Oct') 
        fluxsource= 5.21E+10; 
    else 
        msgbox('error5') 
    end 
else 










list = which('dose.out','-all'); 
  96 
for i=1:size(list,1) 
     
    [pathstr,name,ext] = fileparts(list{i} 
q)  
      
    cd(pathstr) 
  
    doseimport('dose.out') 




list = which('flux.out','-all'); 
for i=4:size(list,1) 
     
    [pathstr,name,ext] = fileparts(list{i}) ; 
      
    cd(pathstr); 
  
    [earray,bin,headers]=importfluxes('flux.out'); 
    save flux earray bin headers 






DELIMITER = ' '; 
HEADERLINES = 842; 
  
% Import the file 




save dose.mat dosearray 
  







%  Imports data from the specified file 
%  FILETOREAD1:  file to read 
DELIMITER = ' '; 
HEADERLINES = 825; 
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% Import the file 
datastruct = importdata(fileToRead1, DELIMITER, HEADERLINES); 
  
k=1; 
    for i=1:size(datastruct.data,1) 
         
        for j=1:size(datastruct.data,2) 
             
             
            if  ~isnan(datastruct.data(i,j)) 
  
                earray(k)=datastruct.data(i,j); 
                k=k+1; 
            end 
        end 
    end 








    j=(i-1)*4026+867; %%headerlines 
    k=1+i;  %%dataset 
     
    DELIMITER = ' '; 
    HEADERLINES = j; 
     
    filenamo=horzcat('newData',num2str(k)); 
    datanamo=horzcat('data',num2str(k)); 
  
    str1=horzcat(filenamo,'=','importdata(fileToRead1, DELIMITER, 
HEADERLINES);'); 
  
% Import the file 
eval(str1); 
  
% Create new variables in the base workspace from those fields. 
str2=horzcat('bin{i}=',filenamo,'.data;'); 
eval(str2); 
     
























B.3 Mathematica Script for Oxygen Concentration Gradient 
 
params = {d0 -> 1*10^-6, d1 -> 1.5*10^-5, V1 -> .059, K1 -> .075,    u0 -> 0, j0 -> 
0.18995, j1 -> 10.13} tFinal = 720; lFinal = .15; lstratc = .0015;  
 
pde = D[c[x, t], t] ==    Piecewise[{{d0*D[c[x, t], x, x],       x <= lstratc}, {d1*        
D[c[x, t], x, x] - ((V1*c[x, t])/(K1 + c[x, t])), x > lstratc}}] 
 
ic = {c[x, 0] == Piecewise[{{j0, x == 0}, {j1, x == lFinal}}, 0]}  
 
bc1 = c[0, t] == j0 bc2 = c[lFinal, t] == j1 soln = NDSolve[Flatten@{pde, ic, bc1, bc2} 
/. params,    c, {t, 0, tFinal}, {x, 0, lFinal /. params},    Method -> {"MethodOfLines",      
"SpatialDiscretization" -> {"TensorProductGrid",        "MinPoints" -> 1000}}] 
 
  99 
Plot3D[c[x, t] /. soln, {x, 0, lFinal}, {t, 0, tFinal},   ColorFunction -> Function[{x, y, z}, 
RGBColor[.5, .8, z]],   BoxRatios -> 1,   AxesLabel -> {"Depth (cm)", "Time (s)", 
"Concentration mM"},   BaseStyle -> {FontWeight -> "Bold", FontSize -> 20}]  
 
Plot3D[c[x, t] /. soln, {x, 0, lFinal/5}, {t, 0, tFinal/2},   ColorFunction -> Function[{x, y, 
z}, RGBColor[.5, .8, z]],   BoxRatios -> 1,   AxesLabel -> {"Depth (cm)", "Time (s)", 
"Concentration mM"},   BaseStyle -> {FontWeight -> "Bold", FontSize -> 20}]  
ThickSkin = c[x, tFinal] /. soln thick = Plot[ThickSkin, {x, 0.00, lFinal},    AxesLabel -> 
{"Depth (cm)", "Concentration mM"},    PlotStyle -> {Blue, Thick},    PlotLegends -> 
LineLegend[{Blue}, {"Thick Skin"}]] 
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[ T i t l e ] 
proton spectra 1972 KING SPE 1cm thick shield 
 
[ Parameters] 
icntl    =           0     # (D=0) 3:ECH 5:NOR 6:SRC 7,8:GSH 11:DSH 12:DUMP 
!! 0: normal, 7: 2D-geometry plot, 11: 3D-geometry plot. 
!! 
!! It requires [t-gshow] section for icntl=7, and 
!! [t-3dshow] section for icntl=11 
!! 
 maxcas   =       1000000 # (D=10) number of particles per one batch 
 maxbch   =           10     # (D=10) number of batches 
 emin(1) =          1.e-3   # Energy cutoff for proton (MeV) (D=1.0) 
 emin(2)  =        1.0E-6  # (D=1.0) cut-off energy of neutron (MeV) 
 dmax(2)  =        20.00    # (D=emin(2)) data max. energy of neutron (MeV) 
 emin(12) =        1.00E-01 # (D=1.d9) cut-off energy of electron (MeV) 
 emin(13) =        1.00E-01 # (D=1.d9) cut-off energy of positron (MeV) 
 emin(14) =       1.000E-01 # (D=1.d9) cut-off energy of photon (MeV) 
 dmax(12) =  1000.00000     # (D=emin(12)) data max. energy of electron (MeV) 
 dmax(13) =  1000.00000     # (D=emin(13)) data max. energy of positron (MeV) 
 dmax(14) =  1000.00000     # (D=emin(14)) data max. energy of photon (MeV) 
 nlost    =  1000 
 igamma   =           1     # (D=0) photon emission from residual nuclei 
 e-mode   =           1     # (D=0) 0: Normal, 1: Event generator mode 
 nedisp   =           1     # (D=0) 0: no, 1: with e straggling, 10: ATIMA 
 nspred   =           1     # (D=0) 0:no, 1:orig. 2:first Moliere, 10: ATIMA 
 file(6)  = phits.out       # (D=phits.out) general output file name 
 file(7)  = /Applications/phits/data/xsdir.jnd # (D=xdirs) nuclear data input file name 
 file(14) = /Applications/phits/data/trxcrd.dat # (D=trxcrd.dat) photon data input file 
name 
 
[ S o u r c e ] 
s-type = 4           # Cylinder With Energy Distribution 
proj = proton 
r0 =   0.0000        # radius [cm] 
x0 =   0.0000        # (D=0.0) center position of x-axis [cm] 
y0 =   0.0000        # (D=0.0) center position of y-axis [cm] 
z0 =  -5.000         # minimum position of z-axis [cm] 
z1 =  -5.000         # maximum position of z-axis [cm] 
dir =   1.0000       # z-direction of beam [cosine] 
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e-type = 21           # energy bins e(i) and probabilities of the particle generation dN/dE(i) 
by hand 
ne=-100                # (e(i),dN/dE(i),i=1,ne), e(ne+1).  
0.001 924070000 
0.01  923960000 
0.01338088  923800000 
0.01790479  923590000 
0.02390681  923310000 
0.03183221  9.23E+08 
4.21E-02  9.23E+08 
5.51E-02  9.22E+08 
7.11E-02  9.21E+08 
9.03E-02  9.21E+08 
1.12E-01  9.20E+08 
1.38E-01  9.19E+08 
1.66E-01  9.18E+08 
1.97E-01  9.16E+08 
2.30E-01  9.15E+08 
2.68E-01  9.14E+08 
3.08E-01  9.12E+08 
3.53E-01  9.11E+08 
4.01E-01  9.09E+08 
4.54E-01  9.07E+08 
5.13E-01  9.05E+08 
5.77E-01  9.02E+08 
6.48E-01  8.99E+08 
7.26E-01  8.96E+08 
8.13E-01  8.93E+08 
9.09E-01  889720000 
1.014071  885840000 
1.129672  881550000 
1.258328  876870000 
1.399567  871700000 
1.556046  866040000 
1.728746  859840000 
1.919146  853060000 
2.129073  845620000 
2.36107 8.37E+08 
2.62E+00  8.29E+08 
2.90E+00  8.19E+08 
3.21E+00  8.08E+08 
3.55E+00  7.97E+08 
3.93E+00  7.84E+08 
4.35E+00  7.71E+08 
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4.81E+00  7.56E+08 
5.32E+00  7.41E+08 
5.88E+00  7.24E+08 
6.49E+00  7.05E+08 
7.17E+00  6.86E+08 
7.91E+00  6.65E+08 
8.74E+00  6.42E+08 
9.64E+00  6.19E+08 
1.06E+01  5.94E+08 
1.17E+01  5.67E+08 
1.29E+01  5.39E+08 
1.43E+01  5.10E+08 
1.57E+01  4.80E+08 
1.74E+01  4.49E+08 
1.91E+01  4.17E+08 
2.11E+01  3.85E+08 
2.32E+01  3.52E+08 
2.56E+01  3.19E+08 
2.82E+01  2.86E+08 
3.11E+01  2.54E+08 
3.43E+01  2.22E+08 
3.78E+01  1.92E+08 
4.16E+01  1.64E+08 
4.58E+01  1.37E+08 
5.05E+01  1.13E+08 
5.57E+01  9.12E+07 
6.14E+01  7.20E+07 
6.77E+01  5.54E+07 
7.46E+01  4.15E+07 
8.23E+01  3.01E+07 
9.07E+01  2.11E+07 
1.00E+02  1.43E+07 
1.11E+02  9.25E+06 
1.22E+02  5.71E+06 
1.35E+02  3.35E+06 
1.49E+02  1.84E+06 
1.65E+02  9.49E+05 
1.82E+02  4.55E+05 
2.02E+02  1.98E+05 
2.24E+02  7.84E+04 
2.48E+02  2.81E+04 
2.76E+02  8.93E+03 
3.06E+02  2.41E+03 
3.41E+02  5.60E+02 
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3.79E+02  1.07E+02 
4.23E+02  1.65E+01 
4.73E+02  1.97E+00 
5.29E+02  1.77E-01 
5.93E+02  1.10E-02 
6.66E+02  4.64E-04 
7.51E+02  1.21E-05 
8.47E+02  1.79E-07 
9.59E+02  1.23E-09 
1.09E+03  3.84E-12 
1.24E+03  5.37E-15 
1.42E+03  2.18E-18 
1.62E+03  2.15E-22 
1.87E+03  3.97E-27 
2.16E+03  9.88E-33 
2.50E+03   
 
 
[ M a t e r i a l ] 
MAT[ 1 ]   # ICRU soft tissue 
           1H         6.0820000E-02 
          12C         5.5700000E-03 
          14N         1.1180000E-03 
          16O         2.8680000E-02 
MAT[ 2 ]  
           27Al       1.000 
 
[ C e l l ] 
 1          2 -2.7   1 -2 -11  $ Al 
 2          1 -1     2 -4 -11  $ tissue 
98          0       #1 #2 -999    $ Void 
99         -1           999    $ Outer region 
 
[ S u r f a c e ] 
 1            pz    0.0 
 2            pz    1.0 
 4            pz    40.0 
 11           cz    100.0 
999          so   300.0 
 
 
[ T -track ] 
title = flux distribution 
part = proton alpha electron O16 C12 Fe56 
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mesh =  r-z            # mesh type is r-z scoring mesh 
x0 =   0.000000      # center x-position of r-z mesh 
y0 =   0.000000      # center y-position of r-z mesh 
r-type =    2            # r-mesh is linear given by rmin, rmax and nr 
rmin =   0.000000      # minimum value of r-mesh points 
rmax =   25.000000      # maximum value of r-mesh points 
nr =    1            # number of r-mesh points 
z-type =    2            # z-mesh is linear given by zmin, zmax and nz 
zmin =   0.000000      # minimum value of z-mesh points 
zmax =   20.00000      # maximum value of z-mesh points 
nz =  4000            # number of z-mesh points 
e-type = 3            $Energy Mesh - min and max log scale 
ne = 100        $ Number of Mesh points 
emin = 1.e-2     $ min of Mesh 
emax = 5.e3     $ max of mesh 
unit =    1            # unit is [1/cm2/source] 
axis =     z           # axis of  
file = flux.out        # file name of output for the above axis 




[ T - Deposit ] 
title = depth-dose distribution 
mesh =  r-z            # mesh type is r-z scoring mesh 
x0 =   0.000000      # center x-position of r-z mesh 
y0 =   0.000000      # center y-position of r-z mesh 
r-type =    2            # r-mesh is linear given by rmin, rmax and nr 
rmin =   0.000000      # minimum value of r-mesh points 
rmax =   25.000000      # maximum value of r-mesh points 
nr =    1            # number of r-mesh points 
z-type =    2            # z-mesh is linear given by zmin, zmax and nz 
zmin =   0.000000      # minimum value of z-mesh points 
zmax =   20.00000      # maximum value of z-mesh points 
nz =   4000            # number of z-mesh points 
unit =    2            # unit is [MeV/source)] 
letmat =    0            # (D=0) material id for LET, 0: real material 
dedxfnc =    0            # (D=0) user defined multiplier, 0(no), 1, 2  
material =  all            # (D=all) number of specific material 
output =  dose           # total deposit energy 
axis =     z           # axis of output 
file = dose.out        # file name of output for the above axis  
part =  all       
epsout =    1 
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[ T -cross] 
part = proton alpha neutron electron O16 C12 
mesh = reg      $Cell Interface 
reg = 1       $Crossing Surfaces 
r-in r-out area $Crossing Cells 
1 2 .01        
e-type = 3      $Energy Mesh - min and max log scale 
ne = 100        $ Number of Mesh points 
emin = 1.e0     $ min of Mesh 
emax = 5.e3     $ max of mesh 
unit = 1        $ 1/cm2/source 
axis = eng      $ x axis value of output data 
file = cross_particle.out 
output = flux   $ flux by surface crossing 
x-txt = {\it En} (MeV)  
y-txt = {\it Flux} (1/cm^2) 
epsout = 1  $output written to eps file (plot) 
 
 









Filename = cross_particle.out 
[ T - C r o s s ] 
    title = [t-cross] in region mesh 
     mesh =  reg            # mesh type is region-wise 
      reg =    1            # number of crossing regions 
      non     r- in  r-out    area 
        1     1     2     1.0000000E-02 
   e-type =    3            # e-mesh is log given by emin, emax and ne 
     emin =   1.000000      # minimum value of e-mesh points 
     emax =   5000.000      # maximum value of e-mesh points 
#    edel =  8.5171932E-02  # mesh width of e-mesh points 
       ne =  100            # number of e-mesh points 
#    data = ( e(i), i = 1, ne + 1 ) 
#           1.00000E+00  1.08890E+00  1.18571E+00  1.29113E+00  1.40591E+00 
#           1.53091E+00  1.66701E+00  1.81521E+00  1.97659E+00  2.15232E+00 
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#           2.34367E+00  2.55204E+00  2.77892E+00  3.02598E+00  3.29500E+00 
#           3.58794E+00  3.90693E+00  4.25427E+00  4.63249E+00  5.04434E+00 
#           5.49280E+00  5.98114E+00  6.51288E+00  7.09191E+00  7.72241E+00 
#           8.40896E+00  9.15656E+00  9.97061E+00  1.08570E+01  1.18223E+01 
#           1.28733E+01  1.40178E+01  1.52641E+01  1.66211E+01  1.80988E+01 
#           1.97079E+01  2.14600E+01  2.33679E+01  2.54454E+01  2.77076E+01 
#           3.01709E+01  3.28532E+01  3.57740E+01  3.89545E+01  4.24177E+01 
#           4.61888E+01  5.02952E+01  5.47666E+01  5.96356E+01  6.49375E+01 
#           7.07107E+01  7.69972E+01  8.38425E+01  9.12965E+01  9.94131E+01 
#           1.08251E+02  1.17875E+02  1.28355E+02  1.39766E+02  1.52192E+02 
#           1.65723E+02  1.80456E+02  1.96499E+02  2.13969E+02  2.32992E+02 
#           2.53706E+02  2.76261E+02  3.00822E+02  3.27567E+02  3.56689E+02 
#           3.88400E+02  4.22930E+02  4.60531E+02  5.01474E+02  5.46057E+02 
#           5.94604E+02  6.47466E+02  7.05029E+02  7.67709E+02  8.35962E+02 
#           9.10282E+02  9.91210E+02  1.07933E+03  1.17529E+03  1.27978E+03 
#           1.39356E+03  1.51745E+03  1.65236E+03  1.79926E+03  1.95922E+03 
#           2.13340E+03  2.32307E+03  2.52960E+03  2.75450E+03  2.99938E+03 
#           3.26604E+03  3.55640E+03  3.87258E+03  4.21687E+03  4.59177E+03 
#           5.00000E+03 
     unit =    1            # unit is [1/cm^2/source] 
     axis =  eng            # axis of output 
     file = cross_particle.out  # file name of output for the above axis  
   output = flux            # surface crossing flux 
     part =  proton     alpha      neutron    electron   16O        12C       
# kf/name :  2212       2000004    2112       11         8000016    6000012   
    x-txt = {\it En} (MeV) 
    y-txt = {\it Flux} (1/cm^2) 
   epsout =    1            # (D=0) generate eps file by ANGEL 
#    used :        main (  %)        temp (  %)       total (  %) 




#   no. =    1   reg = 1 - 2 
 
x: {\it En} (MeV) 
y: {\it Flux} (1/cm^2) 
p: xlog ylog afac(0.8) form(0.9) 
h: n            x            y(proton  ),hh0l  n  y(alpha   ),hh0dr n  y(neutron ),hh0mb n  
y(electron),hh0ug n  y(16O     ),hh0pc n  y(12C     ),hh0q  n   
#  e-lower      e-upper         flux     r.err       flux     r.err       flux     r.err       flux     r.err       
flux     r.err       flux     r.err  
   1.0000E+00   1.0889E+00   3.0480E-03  0.0597   0.0000E+00  0.0000   1.2016E-02  
0.0478   1.3513E-03  0.2293   0.0000E+00  0.0000   0.0000E+00  0.0000 
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   1.0889E+00   1.1857E+00   3.7138E-03  0.0604   0.0000E+00  0.0000   1.2516E-02  
0.1045   1.2251E-03  0.1373   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.1857E+00   1.2911E+00   3.9047E-03  0.0553   0.0000E+00  0.0000   1.2876E-02  
0.0709   1.5241E-03  0.1241   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.2911E+00   1.4059E+00   4.9058E-03  0.0419   0.0000E+00  0.0000   1.5707E-02  
0.0590   2.0408E-03  0.3049   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.4059E+00   1.5309E+00   5.1376E-03  0.0342   0.0000E+00  0.0000   1.4907E-02  
0.0817   1.3829E-03  0.1407   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.5309E+00   1.6670E+00   5.3888E-03  0.0438   0.0000E+00  0.0000   1.3919E-02  
0.0645   1.2993E-03  0.0856   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.6670E+00   1.8152E+00   7.0587E-03  0.0332   0.0000E+00  0.0000   1.9108E-02  
0.1004   1.5956E-03  0.1680   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.8152E+00   1.9766E+00   8.0747E-03  0.0218   0.0000E+00  0.0000   1.9933E-02  
0.0433   2.1966E-03  0.2938   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.9766E+00   2.1523E+00   9.6994E-03  0.0343   0.0000E+00  0.0000   2.0204E-02  
0.0913   1.7952E-03  0.2597   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.1523E+00   2.3437E+00   1.0748E-02  0.0349   0.0000E+00  0.0000   1.8968E-02  
0.0526   2.5444E-03  0.2918   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.3437E+00   2.5520E+00   1.3068E-02  0.0307   0.0000E+00  0.0000   2.1169E-02  
0.0546   2.1305E-03  0.3023   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.5520E+00   2.7789E+00   1.3635E-02  0.0320   0.0000E+00  0.0000   1.9746E-02  
0.0397   2.4817E-03  0.2890   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.7789E+00   3.0260E+00   1.5871E-02  0.0321   0.0000E+00  0.0000   2.3111E-02  
0.0825   1.7154E-03  0.3315   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.0260E+00   3.2950E+00   1.9720E-02  0.0223   0.0000E+00  0.0000   2.2306E-02  
0.0523   1.2631E-03  0.1612   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.2950E+00   3.5879E+00   2.1977E-02  0.0164   0.0000E+00  0.0000   2.0973E-02  
0.0452   1.5193E-03  0.1814   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.5879E+00   3.9069E+00   2.4936E-02  0.0189   0.0000E+00  0.0000   2.2378E-02  
0.0750   1.4673E-03  0.1109   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.9069E+00   4.2543E+00   2.9447E-02  0.0182   0.0000E+00  0.0000   2.3370E-02  
0.0546   1.1111E-03  0.2027   0.0000E+00  0.0000   0.0000E+00  0.0000 
   4.2543E+00   4.6325E+00   3.4586E-02  0.0114   2.5633E-05  1.0000   2.5070E-02  
0.0590   1.2807E-03  0.2153   0.0000E+00  0.0000   0.0000E+00  0.0000 
   4.6325E+00   5.0443E+00   3.9589E-02  0.0148   1.2550E-05  1.0000   2.6226E-02  
0.0458   1.2451E-03  0.1531   0.0000E+00  0.0000   0.0000E+00  0.0000 
   5.0443E+00   5.4928E+00   4.5661E-02  0.0183   2.1414E-05  0.6668   2.2392E-02  
0.0459   7.7808E-04  0.2353   0.0000E+00  0.0000   0.0000E+00  0.0000 
   5.4928E+00   5.9811E+00   5.3350E-02  0.0151   1.2089E-05  1.0000   2.0653E-02  
0.0491   1.0682E-03  0.2318   0.0000E+00  0.0000   0.0000E+00  0.0000 
   5.9811E+00   6.5129E+00   6.1293E-02  0.0139   2.2771E-05  1.0000   1.9696E-02  
0.0785   5.8419E-04  0.1197   0.0000E+00  0.0000   0.0000E+00  0.0000 
   6.5129E+00   7.0919E+00   7.1451E-02  0.0145   2.7051E-05  0.6667   2.0149E-02  
0.0531   3.9798E-04  0.1906   0.0000E+00  0.0000   0.0000E+00  0.0000 
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   7.0919E+00   7.7224E+00   8.2501E-02  0.0133   1.3276E-04  1.0000   2.1476E-02  
0.0845   4.8237E-04  0.2394   0.0000E+00  0.0000   0.0000E+00  0.0000 
   7.7224E+00   8.4090E+00   9.4910E-02  0.0118   2.8711E-05  1.0000   1.7819E-02  
0.0388   4.6423E-04  0.4994   0.0000E+00  0.0000   0.0000E+00  0.0000 
   8.4090E+00   9.1566E+00   1.0906E-01  0.0057   3.7653E-05  0.7040   1.7956E-02  
0.0451   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   9.1566E+00   9.9706E+00   1.2596E-01  0.0063   0.0000E+00  0.0000   1.7777E-02  
0.0354   4.3955E-05  0.6943   0.0000E+00  0.0000   0.0000E+00  0.0000 
   9.9706E+00   1.0857E+01   1.4598E-01  0.0103   0.0000E+00  0.0000   1.9476E-02  
0.0748   1.3870E-05  1.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.0857E+01   1.1822E+01   1.6863E-01  0.0094   0.0000E+00  0.0000   1.6580E-02  
0.0844   5.1534E-05  0.7354   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.1822E+01   1.2873E+01   1.8756E-01  0.0050   0.0000E+00  0.0000   1.6633E-02  
0.0244   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.2873E+01   1.4018E+01   2.0589E-01  0.0095   0.0000E+00  0.0000   1.6684E-02  
0.0676   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.4018E+01   1.5264E+01   2.2905E-01  0.0062   0.0000E+00  0.0000   1.5295E-02  
0.0504   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.5264E+01   1.6621E+01   2.6127E-01  0.0048   1.0194E-05  1.0000   1.4822E-02  
0.0490   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.6621E+01   1.8099E+01   2.9840E-01  0.0047   0.0000E+00  0.0000   1.6364E-02  
0.0516   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.8099E+01   1.9708E+01   3.4112E-01  0.0059   1.4365E-05  1.0000   1.3258E-02  
0.0619   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.9708E+01   2.1460E+01   3.8507E-01  0.0060   3.2326E-05  0.5098   1.5325E-02  
0.0599   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.1460E+01   2.3368E+01   4.3458E-01  0.0043   1.0324E-05  1.0000   1.3635E-02  
0.0568   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.3368E+01   2.5445E+01   4.7297E-01  0.0041   0.0000E+00  0.0000   1.4479E-02  
0.0774   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.5445E+01   2.7708E+01   4.9455E-01  0.0043   0.0000E+00  0.0000   1.2458E-02  
0.0500   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.7708E+01   3.0171E+01   5.5100E-01  0.0046   0.0000E+00  0.0000   1.0902E-02  
0.0694   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.0171E+01   3.2853E+01   6.0808E-01  0.0036   0.0000E+00  0.0000   1.0541E-02  
0.0567   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.2853E+01   3.5774E+01   6.3245E-01  0.0044   0.0000E+00  0.0000   9.0021E-03  
0.0297   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.5774E+01   3.8954E+01   6.4426E-01  0.0040   1.0268E-05  1.0000   8.0306E-03  
0.0846   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.8954E+01   4.2418E+01   7.0932E-01  0.0037   0.0000E+00  0.0000   7.6089E-03  
0.0634   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   4.2418E+01   4.6189E+01   6.9267E-01  0.0036   0.0000E+00  0.0000   6.6145E-03  
0.1055   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
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   4.6189E+01   5.0295E+01   7.0746E-01  0.0037   0.0000E+00  0.0000   5.7536E-03  
0.0938   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   5.0295E+01   5.4767E+01   7.0367E-01  0.0044   0.0000E+00  0.0000   3.9431E-03  
0.0528   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   5.4767E+01   5.9636E+01   6.7305E-01  0.0036   0.0000E+00  0.0000   4.3752E-03  
0.1371   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   5.9636E+01   6.4937E+01   6.5508E-01  0.0039   1.4212E-05  1.0000   3.1221E-03  
0.0827   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   6.4937E+01   7.0711E+01   6.0428E-01  0.0034   0.0000E+00  0.0000   2.4408E-03  
0.0748   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   7.0711E+01   7.6997E+01   5.4160E-01  0.0023   1.0583E-05  1.0000   1.8902E-03  
0.0903   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   7.6997E+01   8.3843E+01   5.0770E-01  0.0030   0.0000E+00  0.0000   1.4997E-03  
0.0974   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   8.3843E+01   9.1296E+01   4.0596E-01  0.0046   0.0000E+00  0.0000   1.2806E-03  
0.1255   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   9.1296E+01   9.9413E+01   3.6938E-01  0.0044   0.0000E+00  0.0000   8.0938E-04  
0.1213   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   9.9413E+01   1.0825E+02   3.0224E-01  0.0058   0.0000E+00  0.0000   4.9967E-04  
0.1348   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.0825E+02   1.1788E+02   2.1654E-01  0.0044   0.0000E+00  0.0000   3.8567E-04  
0.1622   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.1788E+02   1.2836E+02   1.7707E-01  0.0073   0.0000E+00  0.0000   3.4150E-04  
0.2204   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.2836E+02   1.3977E+02   1.3247E-01  0.0069   0.0000E+00  0.0000   1.4538E-04  
0.2574   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.3977E+02   1.5219E+02   9.1705E-02  0.0113   0.0000E+00  0.0000   7.7339E-05  
0.4758   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.5219E+02   1.6572E+02   5.6479E-02  0.0129   0.0000E+00  0.0000   2.1132E-05  
0.6669   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.6572E+02   1.8046E+02   3.9202E-02  0.0205   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.8046E+02   1.9650E+02   2.5640E-02  0.0181   0.0000E+00  0.0000   4.2253E-05  
0.4086   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.9650E+02   2.1397E+02   1.4186E-02  0.0234   0.0000E+00  0.0000   4.2879E-05  
0.4104   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.1397E+02   2.3299E+02   6.4421E-03  0.0298   0.0000E+00  0.0000   1.0429E-05  
1.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.3299E+02   2.5371E+02   3.8010E-03  0.0387   0.0000E+00  0.0000   1.1654E-05  
1.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.5371E+02   2.7626E+02   1.8502E-03  0.0954   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.7626E+02   3.0082E+02   8.8015E-04  0.1068   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
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   3.0082E+02   3.2757E+02   2.2001E-04  0.2517   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.2757E+02   3.5669E+02   1.4000E-04  0.3049   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.5669E+02   3.8840E+02   2.0000E-05  0.6667   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.8840E+02   4.2293E+02   2.0000E-05  0.6667   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   4.2293E+02   4.6053E+02   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   4.6053E+02   5.0147E+02   1.0000E-05  1.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   5.0147E+02   5.4606E+02   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   5.4606E+02   5.9460E+02   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   5.9460E+02   6.4747E+02   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   6.4747E+02   7.0503E+02   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   7.0503E+02   7.6771E+02   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   7.6771E+02   8.3596E+02   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   8.3596E+02   9.1028E+02   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   9.1028E+02   9.9121E+02   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   9.9121E+02   1.0793E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.0793E+03   1.1753E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.1753E+03   1.2798E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.2798E+03   1.3936E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.3936E+03   1.5174E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.5174E+03   1.6524E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.6524E+03   1.7993E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   1.7993E+03   1.9592E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
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   1.9592E+03   2.1334E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.1334E+03   2.3231E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.3231E+03   2.5296E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.5296E+03   2.7545E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.7545E+03   2.9994E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   2.9994E+03   3.2660E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.2660E+03   3.5564E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.5564E+03   3.8726E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   3.8726E+03   4.2169E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   4.2169E+03   4.5918E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
   4.5918E+03   5.0000E+03   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  
0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000   0.0000E+00  0.0000 
 
#   sum over                 1.4619E+01           4.2291E-04           7.8682E-01           3.5054E-
02           0.0000E+00           0.0000E+00 
'no. =    1   reg = 1 - 2' 
msuc: {\huge [t-cross] in region mesh} 
msdl: {\it plotted by \ANGEL \version} 
msdr: {\it calculated by \PHITS  2.64} 
wt: s(0.7) 
\vspace{-3} 
  region surface crossing 
  area  &=&   1.0000E-02 [cm^2] 
e: 
  
# Information for Restart Calculation 
# This calculation was newly started 
# istdev =  1 # 1:Batch variance, 2:History variance 
# resc2  = 1.00000000000000000E+01 # Total source weight or Total source weight / 
Batch 
# resc3  = 1.00000000000000000E+01 # Total history number or Total batch number 
# maxcas =     1000000 # History / Batch, only used for istdev=1 
# rijklst= 173130845167769.0 # Next initial random number 
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Parameter Definition Values Units 
RPA Pulm. arterial flow res. 0.023 mmHg * s/mL 
RPP Pulm. periph. flow res. 0.0894 mmHg * s/mL 
RPV Pulm. venous flow res. 0.0056 mmHg * s/mL 
RSA Syst. arterial flow res. 0.06 mmHg * s/mL 
RSP Splanchnic periph. flow 
res. 
3.307 mmHg * s/mL 
REP Extra-splanchnic periph. 
res. 
3.52 mmHg * s/mL 
RMPN Skeletal muscle periph. 
flow res. 
4.48 mmHg * s/mL 
RBPN Cerebral periph. flow 
res. 
6.57 mmHg * s/mL 
RHPN Coronary periph. flow 
res. 
19.71 mmHg * s/mL 
RSV Splanchnic venous flow 
res. 
0.038 mmHg * s/mL 
REV Extra-splanchnic venous 
res. 
0.04 mmHg * s/mL 
RMV Skeletal muscle venous 
flow res. 
0.05 mmHg * s/mL 
RBV Cerebral venous flow 
res. 
0.075 mmHg * s/mL 
RHV Coronary venous flow 
res. 
0.224 mmHg * s/mL 
RVC_0 Nominal vena cava flow 
res. 
0.025 mmHg * s/mL 
RLA Left at. flow res. 0.0025 mmHg * s/mL 
RRA Right at. flow res. 0.0025 mmHg * s/mL 
CPA Pulm. arterial 
compliances 
0.76 mL/mmHg 
CPP Pulm. periph. 
compliances 
5.8 mL/mmHg 
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CPV Pulm. venous 
compliances 
25.37 mL/mmHg 
CSA Syst. arterial 
compliances 
0.28 mL/mmHg 
CSP Splanchnic periph. 
compliances 
2.05 mL/mmHg 
CEP Extra-splanchnic periph. 
compliances 
0.668 mL/mmHg 
CMP Skeletal muscle periph. 
compliances 
0.525 mL/mmHg 
CBP Cerebral periph. 
compliances 
0.358 mL/mmHg 
CHP Coronary periph. 
compliances 
0.119 mL/mmHg 
CSV Syst. venous 
compliances 
61.11 mL/mmHg 
CEV Extra-splanchnic venous 
compliances 
20 mL/mmHg 
CMV Skeletal muscle venous 
compliances 
15.71 mL/mmHg 
CBV Cerebral venous 
compliances 
10.71 mL/mmHg 
CHV Coronary venous 
compliances 
3.57 mL/mmHg 
CLA Left at. compliances 19.23 mL/mmHg 
CRA Right at. compliances 31.25 mL/mmHg 
LPA Pulm. arterial inertance 0.00018 mmHg * 
s2/mL 
LSA Syst. arterial inertance 0.00022 mmHg * 
s2/mL 
VUPA Pulm. arterial unstressed 
vol. 
0 mL 
VUPP Pulm. periph. unstressed 
vol. 
123 mL 
VUPV Pulm. venous unstressed 
vol. 
120 mL 
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VUSA Syst. arterial unstressed 
vol. 
0 mL 
VUSP Splanchnic periph. 
unstressed vol. 
274.4 mL 
VUEP Extra-splanchnic periph. 
unstressed vol. 
134.64 mL 
VUMP Skeletal muscle periph. 
unstressed vol. 
105.8 mL 
VUBP Cerebral periph. 
unstressed vol. 
72.13 mL 
VUHP Coronary periph. 
unstressed vol. 
24 mL 
VUSV Splanchnic venous 
unstressed vol. 
1121 mL 
VUEV Extra-splanchnic venous 
unstressed vol. 
550 mL 
VUMV Skeletal muscle venous 
unstressed vol. 
432.14 mL 
VUBV Cerebral venous 
unstressed vol. 
294.64 mL 
VUHV Coronary venous 
unstressed vol. 
98.21 mL 
VVC_0 Vena cava unstressed 
vol. 
130 mL 
VULA Left at. unstressed vol. 25 mL 
VURA Right at. unstressed vol. 25 mL 
VULV Left vent. unstressed 
vol. 
16.77 mL 
VURV Right vent. unstressed 
vol. 
40.88 mL 
Kr_vc Gain for vena cava flow 
res. 
0.001 mmHg*s/mL 
Vvc_max Maximum vol. of vena 
cava 
350 mL 
Vvc_min Minimum vol. of vena 
cava 
50 mL 
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D1 Parameter for P–V curve 
of vena cava 
0.3855 mmHg 
D2 Parameter for P–V curve 
of vena cava 
−5 mmHg 
K1_vc Parameter for P–V curve 
of vena cava 
0.15 mmHg 
K2_vc Parameter for P–V curve 
of vena cava 
0.4 mmHg 
Rcw Chest wall res. 1.03 cmH2O*s/L 
RLT Lung transmural res. 1.69 cmH2O *s/L 
Raw Airway wall res. 1.016 cmH2O *s/L 
Ecw Chest wall elastance 5 cmH2O /L 
ELT Lung transmural 
elastance 
5 cmH2O /L 
k1,aw Const. for upper airway 
pressure 
1.85 cmH2O *s2/ 
L2 
k2,aw Const. for upper airway 
pressure 
0.43 cmH2O *s2/ 
L2 
Dead(i),co2IC Initial cond for ith CO2 
dead space 
39.562 L 
Dead(i),co2IC Initial cond for ith CO2 
dead space 
39.674 L 
Dead(i),co2IC Initial cond for ith CO2 
dead space 
39.813 L 
Dead(i),co2IC Initial cond for ith CO2 
dead space 
40.006 L 
Dead(i),o2IC Initial cond for ith O2 
dead space 
104.36 L 
Dead(i),o2IC Initial cond for ith O2 
dead space 
104.23 L 
Dead(i),o2IC Initial cond for ith O2 
dead space 
104.05 L 
Dead(i),o2IC Initial cond for ith O2 
dead space 
103.8 L 
Vd(i) ith dead space vol. 
(i={1,..4} 
0.03 L 
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PI,co2 Inspiratory CO2 partial 
pressure 
0 Torr 
PI,co2 Inspiratory O2 partial 
pressure 
150 Torr 
Vt' Respiratory flow variable L/sec 
Vt Tidal Vol. variable L 
PdO2 Dead space O2 partial 
pressure 
variable Torr 
PdCO2 Dead space CO2 partial 
pressure 
variable Torr 
Vco2, VLco2 Lungs storage vol. for 
CO2 
3 L 
Vo2, VLo2 Lungs storage vol. for 
O2 
2.5 L 
PAco2IC Initial cond for Partial 
CO2 pressure 
40.943 Torr 
PAo2IC Initial cond for Partial 
O2 pressure 
102.52 Torr 
PAo2IC Initial cond for Partial 
O2 pressure 
102.52 Torr 
PACO2 Alveolar CO2 partial 
pressure 
variable Torr 
PACO2 Alveolar O2 partial 
pressure 
variable Torr 
Palv Alveolar partial gas 
pressure 
variable Torr 
Q Blood flow variable L/sec 
tauchemo Periph. chemoreceptors 
delay time const. 
2 s 
T1 Time const. for 
cardiovascular mixing 
1 s 
T2 Time const. for 
cardiovascular mixing 
2 s 
Ta Lung to chemoreceptor 
circulation delay 
variable s 
LCTV0 Lung to chemoreceptor 0.588 liter 
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transportation vol. 
const. 
PaO2firstIC Initial cond for first 
order Pao2 system 
0.3557 Torr 
PaO2secondIC Initial cond for second 
order Pao2 system 
103.14 Torr 
PaCO2firstIC Initial cond for first 




Initial cond for second 
order Paco2 system 
40.393 Torr 
PaO2_delayIC Initial cond for O2 
convection 
103.12 Torr 
Paco2_delayIC Initial cond for CO2 
convection 
40.445 Torr 
PaCO2 CO2 partial pressure variable Torr 
PaO2 O2 partial pressure variable Torr 




C2 Maximum carbon 
dioxide concentration 
87 mL/mL 
a1 Parameter in O2 
dissociation equation 
0.3836 dimensionless 
a2 Parameter in CO2 
dissociation equation 
1.819 dimensionless 
alpha1 Parameter in O2 
dissociation equation 
0.02598 dimensionless 
alpha2 Parameter in CO2 
dissociation equation 
0.05591 dimensionless 
K1 Parameter in O2 
dissociation equation 
13 dimensionless 
K2 Parameter in CO2 
dissociation equation 
194.4 dimensionless 
beta1 Parameter in O2 
dissociation equation 
0.012275 dimensionless 
beta2 Parameter in CO2 0.03255 dimensionless 
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dissociation equation 
Sao2_delayIC Initial Cond for Oxygen 
Saturation Delay 
98.92 sec 
MRbco2 Metabolic prod rate for 
CO2 in the brain 
tissue 
0.0517 1/s STPD 
Sco2 Dissociation slope for 
CO2 in the blood 
0.0043 mL/(mL*Torr
) 
Sbco2 Dissociation slope for 
CO2 in the brain tissue 
0.36 mL*100g− 
1/Torr 
Pbco2IC Initial cond for partial 
CO2 pressure from the 
brain 
48.538 Torr 
Vtco2 Body tissue storage vol. 
for CO2 
6 L 
Vto2 Body tissue storage vol. 
for O2 
7.7 L 
MRco2 Metabolic prod rate for 
CO2 
0.0033 1/s STPD 
MRo2 Metabolic consumption 
rate for O2 
0.0038 1/s STPD 








Ruaw Upper airway wall res. 1000000 cmH2O*s/L 
A0ua Maximum area of 
opening in upper airway 
1 a.u. 
Kua Proportionality 
coefficient between Aua 
and Yua; 
1 L/(s*cmH2O) 
Pcrit_awake Critical upper airway 
pressure in wakefulness 
−40 cmH2O 
Sua Upper airway sensitivity 0.01 a.u. 
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to collapse 
Cua Upper airway 
compliance 
variable L/cmH2O 
Pua Upper airway pressure variable cmH2O 
     Upper airway flow variable cmH2O 
   Total flow in airways variable cmH2O 
FlowIC Initial air flow 0 L/s 
VC Vital Capacity 5 L 








FlowIC Initial cond for airflow 0 L/s 
VtIC Initial cond for lung vol.  0 L 
Pn Center pressure for 
sigmoidal function 
92 mmHg 
Kcs Parameter for sigmoidal 
slope control 
11.758 mmHg 
Pn_sleep Parameter for sleep 
effects 
0 mmHg 
Kcs_sleep Parameter for sleep 
effect 
0 mmHg 
fcs,min Lower threshold for 
sigmoidal function 
2.52 spikes/s 
fcs,max Upper saturation for 
sigmoidal function 
47.78 spikes/s 
τZ Time const. for 
baroreflex 
6.37 s 
τP Time const. for 
baroreflex 
2.076 s 
Ic Central apneic threshold 45 dimensionless 
IpCO2 Periph. apneic threshold 
for CO2 
38 dimensionless 
IpO2 Periph. apneic threshold 102.4 dimensionless 
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for O2 
Gc Gain for central 
chemical drive 
0.075 dimensionless 
Gp Gain for periph. 
chemical drive 
0.0063 dimensionless 
Swake Factor of wakefulness to 
sleep 
0.3 dimensionless 




Vb Basal ventilation 6.7 L/min 
TD Chemoreflex drive 
threshold 
1539 mL 
TP Chemoreflex drive 
threshold 
2879 mL 
S1F Scaling factor 0.00518 dimensionless 
S1V Scaling factor 0.024 dimensionless 
S2F Scaling factor 0.0105 dimensionless 
S2V Scaling factor 0.0367 dimensionless 
fchemo,max Upper saturation for the 
sigmoidal function 
12.3 spikes/s 





Basal level for the 
chemoreflex 
1.4 dimensionless 
Kchemo Slope control parameter 
for the sigmoidal 
function 
29.27 mmHg 
KH Const. value for the 
static response 
3 dimensionless 
τchemo Time const. for the 
chemoreflex 
2 s 
Gls Const. gain 23.29 spikes/sec/liter 
τls Time const. 2 sec 
Xsa Saturation for the offset 
of α-sympathetic activity 
on periph. res. 
6 Torr 
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θsan Nominal level of offset 
of α-sympathetic activity 
on periph. res. 
13.2 spikes/sec 
PO2nsa Central point for the 
sigmoidal function 
30 Torr 
kiscsa Parameter of α-
sympathetic activity on 
periph. res. 
2 dimensionless 
Xsb Saturation for the offset 
of β sympathetic activity 
21.2 Torr 
θsbn Nominal level of offset 
of β-sympathetic activity 
3.6 spikes/sec 
PO2nsb Central point for the 
sigmoidal function 
45 Torr 
kiscsb Parameter of β-
sympathetic activity 
4 dimensionless 
Xsp Saturation for the offset 
of α-sympathetic activity 
on periph. res. 
6 dimensionless 
θspn Nominal level of offset 
of α-sympathetic activity 
on periph. res. 
13.2 spikes/sec 
PO2nsp Central point for the 
sigmoidal function 
30 Torr 
kiscsp Parameter of α-
sympathetic activity on 
unstressed 
vol. of veins 
2 dimensionless 
τisc Time const. for oxygen 
response 
30 s 
τcc Time const. for carbon 
dioxide response 
20 s 
fcs,0 Center point for the 
sigmoidal function for 
parasympathetic 
25 spikes/s 
fpara,0 Lower saturation of the 
parasympathetic 
3.2 spikes/s 
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exponential decay 
function 





kp Slope control parameter 
for the sigmoidal 
function 
7.06 dimensionless 








Glung, p Lung stretch receptor 













Ks Const. for the 
exponential function 
0.07 s 
G_RSA,bs Central RSA gain for β-
sympathetic response 
0.4 dimensionless 
Gchemo,bs Chemoreflex gain for β-
sympathetic response 
2.8 dimensionless 
Glung,bs Lung stretch receptor 
reflex gain for β- 
sympathetic 
0.24 dimensionless 
G_RSA,as Central RSA gain for α-
sympathetic response 
0.4 dimensionless 
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Gchemo,as Chemoreflex gain for α-
sympathetic response 
4 dimensionless 
Glung,as Lung stretch receptor 
reflex gain for α- 
sympathetic 
0.34 dimensionless 
ftbsIC β-sympathetic initial 
output after time delay 
3.8576 spikes/s 
ftbs_min Lower limit for the 
natural log function 
2.66 spikes/s 
Gbs β-sympathetic Gain 
varied with sleep drive 
−0.13 dimensionless 
Gbs_sleep β-sympathetic sleep gain 
factor 
0.2 dimensionless 
τbs β-sympathetic time 
const. 
2 s 
Dbs Delay for β-sympathetic 
time const. 
2 s 
ftpIC Para sympathetic initial 
output after time delay 
4.2748 spikes/s 
Gpara Parasympathetic Gain 
varied with sleep drive 
0.09 dimensionless 
Gpara_sleep Parasympathetic sleep 
gain factor 
0.2 dimensionless 
τpara Parasympathetic time 
const. 
1.5 s 




Inhale Boolean variable for 
inhalation 
1 dimensionless 
HPbasal Basal value for HP for 
denervated heart 
0.58 s 




Dlv Delay for elastance of 
lft. vent. 
2 s 
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τlv Time const. for 
elastance of lft. vent. 
8 s 
Emax0_lv Basal level of maximum 








Drv Delay for elastance of 
rht. vent. 
2 s 
τrv Time const. for 
elastance of rht. vent. 
8 s 
Emax0_rv Basal level of maximum 




fasIC α-sympathetic initial 
output after time delay 
34.793 spikes/s 
fas_min Lower limit for the 
natural log function 
2.66 spikes/s 
Gas_sleep α-sympathetic Gain 
varied with sleep 
0.3 dimensionless 
Gas_sp α-sympathetic Gain for 
splanchnic periph. res. 
0.695 dimensionless 
τas_sp α-sympathetic time 
const. 
2 s 
Das_sp Delay α-sympathetic 
time const. 
2 s 




τas_ep α-sympathetic time 
const. 
2 s 
Das_ep Delay α-sympathetic 
time const. 
2 s 
Gas_mp α-sympathetic Gain for 
skeletal muscle periph. 
res. 
2.47 dimensionless 
  125 
τas_mp α-sympathetic time 
const. 
2 s 
Das_mp Delay α-sympathetic 
time const. 
2 s 
Vusv0 Basal level of unstressed 
vol. of splanchnic 
venous circulation 
1435.4 ml 
Gas_usv α-sympathetic Gain for 




τas_usv α-sympathetic time 
const. 
20 s 
Das_usv Delay α-sympathetic 
time const. 
5 s 
PaCO2_n Nominal arterial CO2 
partial pressure i 
40 Torr 
CvO2n_b Nominal venous O2 
concentration in cerebral 
periph. circulation 
0.14 dimensionless 
CvO2n_m Nominal venous O2 









Tau_CO2 Time const. for periph. 
CO2 response 
20 s 
Tau_O2 Time const. for periph. 
O2 response 
10 s 
A Parameter for flow 
regulation equation 
20.9 dimensionless 
B Parameter for flow 
regulation equation 
92.8 dimensionless 
C Parameter for flow 10570 dimensionless 
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regulation equation 
GO2_b Gain of local O2 




GO2_h Gain of local O2 




GO2_m Gain of local O2 




A Amplitude of the 
skewed sine function 
20.9 dimensionless 
XH Bias of the skewed sine 
function for process CH 
0.9 dimensionless 
XL Bias of the skewed sine 
function for process CL 
0.15 dimensionless 
αgc Const. for sleep 
decaying 
0.2/60 dimensionless 
αrc Rising rate of slow wave 
activity 
0.4/60 dimensionless 
αfc Falling rate of slow 
wave activity 
0.008/60 dimensionless 
SWAo Initial value of sleep 
wake activity 
0.007 dimensionless 
 
 
 
 
 
 
 
 
 
